Patent Grant
8979929
The present invention generally relates to apparatus and methods employed in minimally invasive surgical procedures and more particularly to such apparatus and methods in orthopedic procedures for separating and/or supporting tissue layers.
A variety of physical conditions involve two tissue surfaces that, for diagnosis or treatment of the condition, need to be separated or distracted from one another and then supported in a spaced-apart relationship. Such separation or distraction may be to gain exposure to selected tissue structures, to apply a therapeutic pressure to selected tissues, to return or reposition tissue structures to a more normal or original anatomic position and form, to deliver a drug or growth factor, to alter, influence or deter further growth of select tissues or to carry out other diagnostic or therapeutic procedures. Depending on the condition being treated, the tissue surfaces may be opposed or contiguous and may be bone, skin, soft tissue, or a combination thereof.
One such a condition that occurs in the orthopedic field is vertebral compression fractures. Vertebral compression fractures affect a significant part of the population, and add significant cost to the health care system. A vertebral compression fracture is a crushing or collapsing injury to one or more vertebrae. Vertebral fractures are generally but not exclusively associated with osteoporosis, metastasis, and/or trauma. Osteoporosis reduces bone density, thereby weakening bones and predisposing them to fracture. The osteoporosis-weakened vertebrae can collapse during normal activity and are also more vulnerable to injury from shock or other forces acting on the spine. In severe cases of osteoporosis, actions as simple as bending forward can be enough to cause a vertebral compression fracture. Vertebral compression fractures are the most common type of osteoporotic fractures according to the National Institute of Health.
The mechanism of such vertebral fractures is typically one of flexion with axial compression where even minor events can cause damage to the weakened bone. While the fractures may heal without intervention, the crushed bone may fail to heal adequately. Moreover, if the bones are allowed to heal on their own, the spine may be deformed to the extent the vertebrae were compressed by the fracture. Spinal deformity may lead to breathing and gastrointestinal complications, and adverse loading of adjacent vertebrae.
Vertebral fractures happen most frequently at the thoracolumbar junction, with a relatively normal distribution of fractures around this point. Vertebral fractures can permanently alter the shape and strength of the spine. Commonly, they cause loss of height and a humped back. This disorder (called kyphosis or “dowager's hump”) is an exaggeration of the spinal curve that causes the shoulders to slump forward and the top of the back to look enlarged and humped. In severe cases, the body's center of mass is moved further away from the spine resulting in increased bending moment on the spine and increased loading of individual vertebrae.
Another contributing factor to vertebral fractures is metastatic disease. When cancer cells spread to the spine, the cancer may cause destruction of part of the vertebra, weakening and predisposing the bone to fracture.
Osteoporosis and metastatic disease are common root causes leading to vertebral fractures, but trauma to healthy vertebrae can also cause fractures ranging from minor to severe. Such trauma may result from a fall, a forceful jump, a car accident, or any event that compresses or otherwise stresses the spine past its breaking point. The resulting fractures typically are compression fractures or burst fractures.
Vertebral fractures can occur without pain. However, they often cause a severe “band-like” pain that radiates from the spine around both sides of the body. It is commonly believed that the source of acute pain in compression fractures is the result of instability at the fracture site, allowing motion that irritates nerves in and around the vertebrae.
Until recently, treatment of vertebral compression fractures has consisted of conservative measures including rest, analgesics, dietary, and medical regimens to restore bone density or prevent further bone loss, avoidance of injury, and bracing. Unfortunately, the typical patient is an elderly person. As a class of patients, the elderly generally do not tolerate extended bed rest well. As a result, minimally invasive surgical methods for treating vertebral compression fractures have recently been introduced and are gaining popularity.
One technique used to treat vertebral compression fractures is injection of bone filler into the fractured vertebral body. This procedure is commonly referred to as percutaneous vertebroplasty. Vertebroplasty involves injecting bone filler (for example, bone cement, allograph material or autograph material) into the collapsed vertebra to stabilize and strengthen the crushed bone.
In vertebroplasty, physicians typically use one of two surgical approaches to access thoracic and lumbar vertebral bodies: transpedicular or extrapedicular. The transpedicular approach involves the placement of a needle or wire through the pedicle into the vertebral body, and the physician may choose to use either a unilateral access or bilateral transpedicular approach. The extrapedicular technique involves an entry point through the posterolateral corner of the vertebral body.
Regardless of the surgical approach, the physician generally places a small diameter guide wire or needle along the path intended for the bone filler delivery needle. The guide wire is advanced into the vertebral body under fluoroscopic guidance to the delivery point within the vertebra. The access channel into the vertebra may be enlarged to accommodate the delivery tube. In some cases, the delivery tube is placed directly into the vertebral body and forms its own opening. In other cases, an access cannula is placed over the guide wire and advanced into the vertebral body. After placement, the cannula is replaced with the delivery tube, which is passed over the guide wire or pin. In both cases, a hollow needle or similar tube is placed through the delivery tube into the vertebral body and used to deliver the bone filler into the vertebra.
In this procedure, the use of lower viscosity bone filler and higher injection pressures tend to disperse the bone filler throughout the vertebral body. However, such procedures dramatically increase the risk of bone filler extravasation from the vertebral body. The transpedicular approach requires use of a relatively small needle (generally 11 gauge or smaller). In general, the small diameter needle required for a transpedicular approach necessitates injecting the bone filler in a more liquid (less viscous) state. Further, the pressure required to flow bone filler through a small gauge needle is relatively high. The difficulty of controlling or stopping bone filler flow into injury-sensitive areas increases as the required pressure increases. In contrast, the extrapedicular approach provides sufficient room to accommodate a larger needle (up to about 6 mm internal diameter in the lumbar region and lower thoracic regions). The larger needle used in the extrapedicular approach allows injection of bone filler in a thicker, more controllable viscous state. Therefore, many physicians now advocate the extrapedicular approach so that the bone filler may be delivered through a larger cannula under lower pressure. However, the transpedicular approach is still the preferred approach. Caution, however, must still be taken to prevent extravasation, with the greatest attention given to preventing posterior extravasation because it may cause spinal cord trauma. Physicians typically use repeated fluoroscopic imaging to monitor bone filler propagation and to avoid flow into areas of critical concern. If a foraminal leak results, the patient may require surgical decompression and/or suffer paralysis.
Another type of treatment for vertebral fractures is known as Kyphoplasty. Kyphoplasty is a modified vertebral fracture treatment that uses one or two balloons, similar to angioplasty balloons, to attempt to reduce the fracture and, perhaps, restore some vertebral height prior to injecting the bone filler. One or two balloons are typically introduced into the vertebra via bilateral transpedicular cannula. The balloons are inflated to reduce the fracture. After the balloon(s) are deflated and removed, leaving a relatively empty cavity, bone cement is injected into the vertebra. In theory, inflation of the balloons may restore some vertebral height. However, in practice it is difficult to consistently attain meaningful and predictable height restoration. The inconsistent results may be due, in part, to the manner in which the balloon expands in a compressible media, such as the cancellous tissue within the vertebrae, and the structural orientation of the trabecular bone within the vertebra, although there may be additional factors as well.
Thus there is a need for devices and methods to treat the above mentioned diseases, in particular compression vertebral fractures.
Another condition that can be treated by distraction or separation of tissue layers is disruption or degeneration of an intervertebral disk. An intervertebral disk is made up of strong connective tissue which holds one vertebra to the next and acts as a cushion between vertebras. The disk is divided into two distinct regions: the nucleus pulposus and the annulus fibrosus. The nucleus lies at the center of the disk and is surrounded and contained by the annulus. The annulus contains collagen fibers that form concentric lamellae that surround the nucleus. The collagen fibers insert into the endplates of the adjacent vertebral bodies to form a reinforced structure. Cartilaginous endplates are located at the interface between the disk and the adjacent vertebral bodies.
Proper disk height is necessary to ensure proper functionality of the intervertebral disk and spinal column. The disk serves several functions, although its primary function is to facilitate mobility of the spine. In addition, the disk provides for load bearing, load transfer and shock absorption between vertebral levels. The weight of the person generates a compressive load on the disks, but this load is not uniform during typical bending movements. During forward flexion, the posterior annular fibers are stretched while the anterior fibers are compressed. In addition, a translocation of the nucleus occurs as the center of gravity of the nucleus shifts away from the center and towards the extended side.
Changes in disk height can have both local and broader effects. On the local (or cellular) level, decreased disk height results in increased pressure in the nucleus, which can lead to a decrease in cell matrix synthesis and an increase in cell necrosis and apoptosis. In addition, increases in intra-diskal pressure create an unfavorable environment for fluid transfer into the disk, which can cause a further decrease in disk height.
Decreased disk height may also result in significant changes in the overall mechanical stability of the spine. With decreasing height of the disk, the facet joints bear increasing loads and may undergo hypertrophy and degeneration, and may even act as a source of pain over time. Increased stiffness of the spinal column and decreased range of motion resulting from loss of disk height can lead to further instability of the spine, as well as back pain. Radicular pain may result from a decrease in foraminal volume caused by decreased disk height. Specifically, as disk height decreases, the volume of the foraminal canal, through which the spinal nerve roots pass, decreases. This decrease may lead to spinal nerve impingement, with associated radiating pain and dysfunction.
Finally, adjacent segment loading increases as the disk height decreases at a given level. The disks that must bear additional loading are susceptible to accelerated degeneration and compromise, which may eventually propagate along the destabilized spinal column.
In spite of all of these detriments that accompany decreases in disk height, where the change in disk height is gradual many of the ill effects may be “tolerable” to the spine and may allow time for the spinal system to adapt to the gradual changes. However, a sudden decrease in disk volume caused by surgical removal of the disk or disk nucleus can heighten the local and global problems noted above.
The many causes of disruption or degeneration of the intervertebral disk can be generally categorized as mechanical, genetic and biochemical. Mechanical damage can include herniation in which a portion of the nucleus pulposus projects through a fissure or tear in the annulus fibrosus. Genetic and biochemical causes can result in changes in the extracellular matrix pattern of the disk and a decrease in biosynthesis of extracellular matrix components by the cells of the disk. Degeneration is a progressive process that usually begins with a decrease in the ability of the extracellular matrix in the central nucleus pulposus to bind water due to reduced proteoglycan content. With a loss of water content, the nucleus becomes desiccated resulting in a decrease in internal disk hydraulic pressure that ultimately results in a loss of disk height. This loss of disk height can cause non-tensile loading and buckling of the annulus. The loss of disk height also causes the annular lamellae to delaminate, resulting in annular fissures and rupture of the annulus. Herniation may then occur as rupture leads to protrusion of the nucleus.
Many disk defects are treated through a surgical procedure, such as a diskectomy in which the nucleus pulposus material is removed. During a total diskectomy, a substantial amount (and usually all) of the volume of the nucleus pulposus is removed and immediate loss of disk height and volume can result. Even with a partial diskectomy, loss of disk height can ensue.
Diskectomy alone is the most common spinal surgical treatment. The procedure is frequently used to treat radicular pain resulting from nerve impingement by a disk bulge or disk fragments contacting the spinal neural structures.
In another common spinal procedure, the diskectomy may be followed by an implant procedure in which a prosthesis is introduced into the cavity left in the disk space after the nucleus material is removed. Thus far, the most prominent prosthesis is a mechanical device or a “cage” that is sized to restore the proper disk height and is configured for fixation between adjacent vertebrae. These mechanical solutions take on a variety of forms including solid kidney-shaped implants, hollow blocks filled with bone growth material, and threaded cylindrical cages.
A challenge of inserting a disk implant posteriorly is that a device large enough to contact the endplates and slightly expand the intervertebral space between the endplates must be inserted through a limited space. This challenge is often further heightened by the presence of posterior osteophytes, which may cause converging or “fish mouthing” of the posterior endplates that results in very limited access to the disk. A further challenge in degenerative disk spaces is the tendency of the disk space to assume a lenticular shape, which requires a relatively larger implant that often is not easily introduced without causing trauma to the nerve roots. The size of rigid devices that may safely be introduced into the disk space is thereby limited.
Cages of the prior art have been generally successful in promoting fusion and approximating proper disk height. Cages inserted from the posterior approach, however, are limited in size by the interval between the nerve roots. Some examples of prior art devices are shown in U.S. Pat. No. 5,015,247 to Michelson, which describes an artificial threaded spinal fusion implant; U.S. patent application Ser. No. 10/999,727 to Foley et al., which describes vertebral spacer devices for repairing damaged vertebral disks; U.S. Pat. No. 4,309,777 to Patil, which describes a motion preserving implant that has spiked outer surfaces to resist dislocation and contains a series of springs to urge the vertebrae away from each other; and finally, U.S. patent application Ser. No. 10/968,425 to Enayati, which describes an expandable intervertebral prosthesis. All the above patents and patent applications are hereby incorporated herein by reference.
Therefore, a need remains for a device that can be inserted into an intervertebral disk space in a minimally invasive procedure and is large enough to contact and separate adjacent vertebral endplates. There also remains a need for a device that reduces potential trauma to the nerve roots and still allows restoration of disk space height.
Another related area in which tissue distraction may be required is spinal fusion. Fusion is a surgical technique in which one or more of the vertebrae of the spine are united together (“fused”) so that motion no longer occurs between them. In spinal fusion surgery, bone grafts are placed around the spine, and the body then heals the grafts over several months—similar to healing a fracture—and joins or “fuses” the vertebrae together.
There are many potential reasons for a surgeon to consider fusing vertebrae, such as treatment of fractured (broken) vertebra, correction of deformity (spinal curves or slippages), elimination of pain from painful motion, treatment of instability, and treatment of some cervical disk herniations.
One of the more common reasons to conduct spinal fusion is to treat a vertebral fracture. Although not all spinal fractures need surgery, some fractures, particularly those associated with spinal cord or nerve injury, generally require fusion as part of the surgical treatment. Certain types of spinal deformity, such as scoliosis, also are commonly treated with spinal fusion. Scoliosis is an “S” shaped curvature of the spine that sometimes occurs in children and adolescents. Fusion can be used as a form of treatment for very large curves or for progressively worsening smaller curves. Additionally, fusion can be used to treat spondylolisthesis, which is a condition that occurs when hairline fractures allow vertebrae to slip forward on top of each other.
Another condition that is treated by fusion surgery is actual or potential instability. Instability refers to abnormal or excessive motion between two or more vertebrae. It is commonly believed that instability can either be a source of back or neck pain or cause potential irritation or damage to adjacent nerves. Although there is some disagreement on the precise definition of instability, many surgeons agree that definite instability of one or more segments of the spine can be treated by fusion.
Cervical disk herniations that require surgery usually need removal of the herniated disk (diskectomy) and fusion. With this procedure, the disk is removed through an incision in the front of the neck (anteriorly) and a small piece of bone is inserted in place of the disk. Although disk removal is commonly combined with fusion in the neck, this is not generally true in the low back (lumbar spine).
Spinal fusion is also sometimes considered in the treatment of a painful spinal condition without clear instability. A major obstacle to the successful treatment of spine pain by fusion is the difficulty in accurately identifying the source of a patient's pain. The theory is that pain can originate from painful spinal motion, and fusing the vertebrae together to eliminate the motion will eliminate the pain.
There are many surgical approaches and methods to fuse the spine, and they all involve placement of a bone graft between the vertebrae. The spine may be approached and the graft placed either from the back (posterior approach), from the front (anterior approach) or by a combination of both. In the neck, the anterior approach is more common and in the lumbar and thoracic regions a posterior approach is usually employed.
The ultimate goal of fusion is to obtain a solid union between two or more vertebrae. Fusion may or may not involve the use of supplemental hardware (instrumentation), such as plates, rods, screws and cages. Instrumentation can sometimes be used to correct a deformity, but it usually is just used as an internal splint to hold the vertebrae together while the bone grafts heal. Whether or not hardware is used, bone or bone substitutes are commonly used to get the vertebrae to fuse together. The bone may be taken either from another bone in the patient (autograft) or from a bone bank (allograft).
Yet another related area in which tissue distraction may be required is in the replacement of essentially an entire or a partially removed vertebra. Such removal is generally necessitated by extensive vertebral fractures, or tumors, and is not usually associated with the treatment of disk disease. Vertebral bodies may be compromised due to disease, defect, or injury. In certain cases, it becomes necessary to remove or replace one or more of the vertebral bodies or disks to alleviate pain or regain spinal functionality.
In the treatment of a removed vertebra, a device is used to form a temporary structural mechanical support that aids in replacing the removed vertebra with bone filler, such as calcium phosphate which promotes healing. A number of methods and devices have been disclosed in the prior art for replacing a diseased or damaged vertebral body. These prior art devices and the procedures associated therewith have difficulty in maintaining the proper structural scaffolding while a castable material, such as bone cement, is hardened in the cavity left by the removed vertebral body. The maintaining of proper structural scaffolding has been especially difficult in a minimally invasive posterior surgical approaches.
Spinal fusion or lumbar spinal fusion is one way to treat a compromised vertebral body due to unstable burst fractures, severe compression fractures, and tumor decompression. In a spinal fusion procedure, the disks above and below the compromised vertebral body are removed and a strut graft and plate are then used to make the vertebrae above and below the replaced vertebral body grow together and become one bone.
Some of the prior art vertebral body replacement systems include U.S. Pat. No. 6,086,613 to Camino et al., which describes an interbody fusion system made of a titanium mesh and endplates; U.S. Pat. No. 5,192,327 to Brantigan, which describes the use of singular or stackable modular implants; U.S. Pat. No. 6,585,770 to White et al., which describes a hollow body with an opening to receive bone growth inducing material; and U.S. Pat. No. 6,758,862 to Berry, which describes a vertebral replacement body device. All of the aforementioned references are hereby incorporated herein by reference.
Thus, there remains a need for improved devices for replacing one or more removed or partially removed vertebral bodies especially from a posterior approach and in a minimally invasive surgical intervention.
The present invention addresses many of the shortcomings in the prior devices and methods by providing a distraction device that separates or distracts tissue layers and maintains such separation.
A first aspect of the invention generally relates to distraction device systems for treating the human spine. The distraction device systems preferably comprise at least one guide member for guiding a generally elongated member to a location between the tissue layers of the spine. The guide member has a proximal end portion and a distal end portion. The distal end portion of the guide member is adapted to be inserted between tissue layers and defines a shape of a desired support structure. The elongated member is slidably mounted on the guide member for advancing the elongated member distally along the guide member to insert the elongated member between the tissue layers. The elongated member substantially conforms to the shape defined by the distal end portion of the guide member to form a support structure that separates, supports or both separates and supports the tissue layers.
Another aspect of the invention relates to distraction systems for treating the human spine. In one embodiment, the distraction system can include at least one guide member for guiding a distraction device to a location between the tissue layers of the spine. The guide member has a proximal end portion and a distal end portion. The distal end portion of the guide member is adapted to be inserted between tissue layers and defines a shape of a multi-tiered support structure. The distraction device is slidably mounted on the guide member for advancing the distraction device distally along the guide member to insert the distraction device between the tissue layers. The distraction device substantially conforms to the shape defined by the distal end portion of the guide member to form a multi-tiered support structure that separates, supports or both separates and supports the tissue layers.
Another aspect of the invention relates to intravertebral distraction systems for the treatment of vertebral defects and injuries, such as compression fracture. In one embodiment, the distraction system generally comprises at least one guide member for guiding a distraction device to a location within a vertebral body. The guide member has a proximal end portion and a distal end portion. The distal end portion of the guide member is adapted to be inserted into the vertebral body and defines a shape of a desired support structure. The distraction device is slidably mounted on the guide member for advancing the distraction device distally along the guide member for insertion into the vertebral body. The distraction device substantially conforms to the shape defined by the distal end portion of the guide member to form a support structure that separates, supports or both separates and supports the superior and inferior endplates.
Yet another aspect of the present invention relates to an intervertebral distraction system insertable between endplates of a superior vertebra and an inferior vertebra. In one embodiment, the distraction system comprises at least one guide member for guiding a distraction device to a location between a superior vertebra and an inferior vertebra. The guide member has a proximal end portion and a distal end portion. The distal end portion of the guide member is adapted to be inserted between the superior and inferior vertebrae and defines a shape of a multi-tiered support structure. The distraction device is slidably mounted on the guide member for advancing the distraction distally along the guide member for insertion between the superior and inferior vertebrae. The distraction device substantially conforms to the shape defined by the distal end portion of the guide member to form a multi-tiered support structure that separates, supports or both separates and supports the superior and inferior vertebrae.
These and other aspects of the present invention are set forth in the following detailed description. In that respect, it should be noted that the present invention includes a number of different aspects which may have utility alone and/or in combination with other aspects. Accordingly, the above summary is not exhaustive identification of each such aspect that is now or may hereafter be claimed, but represents an overview of the present invention to assist in understanding the more detailed description that follows. The scope of the invention is as set forth in the claims now or hereafter filed.
In the course of this description, reference will be made to the accompanying drawings, wherein:
Turning now to a detailed description of illustrated embodiments of the present invention. The apparatus or device of the present invention, which is generally defined as a distraction device, can serve to actively separate tissue layers by engaging them and forcing them apart, or to support the separation of tissue layers separated by the distraction device itself or by other devices or processes or a combination of these. Accordingly, the term “distracting device” is intended to have a general meaning and is not limited to devices that only actively separate tissue layers, only support tissue layers or only both actively separate and support tissue layers. For example, the distraction device in general can be used to actively separate layers of tissue and then be removed after such separation, or the distraction device could be used to support layers of tissue that have been previously separated by a different device. Alternatively, the distraction device can be used to actively separate the layers of tissue and remain in place to support the layers of tissue in order to maintain such separation. Unless more specifically set forth in the claims, as used herein, “distraction device” encompasses any and all of these.
It should also be understood that various embodiments of the device, system and method of the present invention are illustrated for purposes of explanation in the treatment of vertebral compression fractures, height restoration of a diseased disk, vertebral fusion procedures and/or replacement of removed disks or vertebra. However, in its broader aspects, the present invention is not limited to these particular applications and may be used in connection with other tissue layers, such as soft tissue layers, although it has particular utility and benefit in treatment of vertebral conditions.
When deployed between tissue layers, as shown in
Preferably, the support structure 141 includes or defines an innerspace or resident volume 145. As used herein, “resident volume” refers generally to a structural characteristic of the support structure. The resident volume is a volume that is generally defined by the distraction device, when it is in the deployed configuration. The resident volume is not necessarily a volume completely enclosed by the distraction device and can be any volume generally defined by the distraction device. This term does not necessarily mean that the resident volume is an open or void volume or cavity and does not preclude a situation in which the resident volume is, at some point in time, filled with another material, such as bone filler, cement, therapeutic drugs or the like. It also does not preclude the resident volume from containing undisturbed human tissue that is located or remains within the resident volume during or after deployment of the distraction device, as will be explained in more detail below. For example, if the distraction device is employed to separate adjoining soft tissue layers, such as subcutaneous fat and underlying muscle tissue, the resident volume of the distraction device may be hollow or void of tissue after separation. On the other hand, if inserted into a vertebra having cancellous bone tissue therein, the resident volume will contain undisturbed bone tissue and no void or cavity is formed by the distraction device.
In order to shape the distraction device 136 like a coil or spring, it is helpful to understand the characteristics of a shape memory alloy. Nickel-Titanium alloys, such as Nitinol, exhibit the phenomena of thermal shape memory and superelasticity. The term thermal shape memory refers to the material's ability to return from a plastically deformed shape to a pre-determined shape upon increasing the temperature of the material. The term superelasticity refers to the elastic ability of the material. Materials with superelastic characteristics can be deformed by applying a force to constrain the material in a deformed or constrained shape. Once the force or constraint is removed, the material will substantially return to its pre-determined or initial shape. Superelastic materials, such as Nickel-titanium alloys, can be considerably more elastic than stainless steel. The pre-determined or initial shape can be referred to as the free state and the deformed shape can be referred to as the constrained state.
The initial or pre-determined shape of a shape memory material is normally set by a heat treatment process, which is well known in the art. In the present invention, the material selected is wound on a mandrel and securely attached so it can be heat treated to set the desire shape, in this case, to be configured like a tight pitch coil or helical shape. The heat cycle is typically around 500° C. and for a period of 10 minutes to 60 minutes depending on the strength of the material, spring constant and oxide layer required. The mandrel could range in sizes from about 0.125 to about 2.0 inches, but is preferably around 0.5 inches in diameter. The wind direction could be right hand or left hand, with a tight pitch, having little or no space between adjacent coils or turns. However, other pitches could be used if required by the application, and if the material is of sufficient strength, the coils can be spaced apart.
Because of the shape memory characteristics of the material used in the construction of the distraction device 136, the distraction device can be deformed prior to or during delivery to a desired treatment site, and then returned to its original shape within the treatment site. In other words, the distraction device has an inherent tendency or is predisposed to form itself into its deployed shape. Referring to
The cannula 142 preferably has a lumen 143 and a bore 144 that is complementary to or the same as the cross-section of the distraction device 136. The distraction device 136 can be pushed or pulled through the cannula 142 with the aid of a pushrod 150 or other suitable advancement device. The proximal end 152 of the cannula 142 may have a knob or handle 154 or other structure for ease of use and a proximal end 156 of the pushrod 150 also may have a knob or handle 158 as well.
As shown in
In a typical procedure for treatment of a vertebral compression fracture, access to the vertebra can be gained by using the same procedures and techniques that are used for the other vertebral procedures mentioned above, or by any other procedures and techniques generally known by those skilled in the art. Referring to
The distraction device 136 may be prepositioned within the cannula 142, which constrains the distraction device in the deformed or pre-deployed configuration. As the pushrod 150 is advanced, the distraction device 136 is advanced out of the distal end portion 146 of the cannula 142 and into the cancellous bone 108 of the vertebral body 130. Upon exiting the cannula 142, the distraction device 136 will begin to revert, by change of configuration, to its initial or deployed coil shape to define support structure 141. Thus, as it is advanced from the cannula, the distraction device 136 winds up into the relatively spongy cancellous bone 108 of the vertebral body 130 as shown in
As deployment of the distraction device 136 progresses into the cancellous bone 108 between the endplates 112, 114, in this embodiment, the spring-shaped distraction device support structure 141 will contact the endplates and start to distract the endplates (or actively separate them) apart from each other as the support structure increases in height. The distraction device 136 will be advanced out of the cannula 142 until the distraction device attains the desired height or extent as measured in the direction of endplate separation, or the endplates 112, 114 have been separated by a desired distance. Typically, the distraction device 136 is advanced until the height of the distraction device support structure 141 is such that it returns the endplates 112, 114 to a normal pre-compression position, or such other spacing as the physician deems appropriate as illustrated in
In one embodiment of the present invention, the height of the vertebra is estimated prior to the procedure by measuring adjacent vertebrae, and then an appropriate sized distraction device that will achieve the desired height upon completely exiting the cannula is selected. Alternatively, the height of the distraction device could be monitored during the procedure, and when the desired height is attained, the distraction device (“ribbon”) could be severed at a location near the distal end of the cannula.
Another optional and beneficial aspect of the distraction device of the present invention is the ability to control the delivery of flowable material, such as bone filler, for example bone cement, allograph, autograph or some other biocompatible material, or therapeutic drug into the treatment site. One example of an appropriate bone filler is polymethyl methacrylate (PMMA), commercially available as Kyphx HV-R from Kyphon, Spineplex from Stryker, Simplex from Stryker Howmedica and Parallax Acrylic Resin with Tracers TA from Arthocare. The distraction device also can be used to control the delivery of drugs or other agents or fluids, depending on the application.
For example, once the support structure 141 defined by the distraction device is in place, bone filler 162 can be introduced into the treatment site to assist in stabilization of the distraction device and to aid in supporting the separation of the endplates 112, 114. As illustrated in
The distraction device can have a variety of the cross-sectional profiles configurations, as shown in
In
If desired, the distraction device 136a can include lateral grooves or slots 170 or other lateral passageways at strategic locations. These grooves 170 or other passageways may be formed by drilling, cutting, grinding or compressing the distraction device material. When the distraction device is made of a shape memory material, the grooves or passageways can be formed either before or after winding and heat treating. The grooves 170 can be uniformly or randomly spaced apart and, depending on the desired treatment, located only on one side of the support structure defined by the distraction device. The grooves 170 can be used to direct and limit the flow of bone filler injected into and around the treatment site. For example, as illustrated in
In
The distraction device could also include apertures or holes 182 which extend through the wall 180 and communicate with the internal bore or channel 178. The apertures 182 can be uniformly or randomly spaced apart and may be of the same size or vary in size. Additionally, the apertures 182 could be limited to the inner wall of the distraction device or to the outer wall of the distraction device or could be located on both the inner and outer walls. Further, the apertures 182 could be limited to one side of the distraction device, such as on the anterior side or posterior side. Bone filler can be delivered to the treatment site by inserting the tip of the syringe into the channel 178 and injecting the bone filler into the channel. The bone filler will flow along the channel 178 and escape out of the apertures 182 in the desired directions into the treatment site. The location and arrangement of the apertures will determine the direction of bone filler injected within the treatment site.
The distraction device also may be coated with a polymer based of bone filler material that can be activated upon implantation and diffused into the surrounding tissue. This potential feature is applicable to a distraction device of any cross-sectional shape.
In
In
In
In
In
In
In
In
In
The distraction devices of the present invention may also be used in intervertebral disk treatments and intervertebral body fusion procedures, as well as, total or partial vertebral body replacements procedures. One of the advantages of the present invention is the ability to use the device in a minimally invasive surgery setting that allows the surgeon to use an endoscopic approach to remove damaged spinal tissue due to disease, such as trauma or tumor and to deploy the device into the space created by such removal.
In one minimally invasive method of an intervertebral disk treatment or intervertebral body fusion procedure in accordance with the present invention, a disk nucleus removal tool 190, such as rongeurs, curettes, probes or dissectors, is inserted through a small access hole 191 in the annulus fibrous 192 of an intervertebral disk 193, as illustrated in
Referring to
In a procedure in which the distraction device 136 is designed to be advanced completely out of the cannula 142, the desired height of the support structure 141 is pre-determined and a distraction device of an appropriate size is chosen for use. In a procedure in which the distraction device 136 is deployed until the desired height of the support structure 141 is attained, the height of the support structure may be monitored under fluoroscopy, and once the support structure has reached the desired height, the distraction device may be severed at a location near the distal end portion of the cannula.
Upon deployment, the distraction device restores disk height and stabilizes the vertebral column. Depending on the amount of nucleus pulpous tissue removed and the deployment location of the support structure, the resident volume of the support structure may be substantially empty or may contain some nucleus pulpous tissue. Optionally, bone filler, such as bone cement, allograph or autograph, or other therapeutic drugs may be inserted into the resident volume defined by the support structure and/or around the support structure to aid in stabilization of the device and/or to promote bone fusion between the adjacent vertebrae.
The prior art device illustrated in
In one minimally invasive partial VBR procedure of the present invention, a vertebral bone removal tool 197 is inserted through a small access hole 160c of a vertebral body 130c as illustrated in
Referring to
In one minimally invasive method of a total VBR procedure, the vertebral body removal tool described above is used to move substantially all of a vertebral body, and optionally, a disk removal tool is used to substantially remove the adjacent disks. Referring to
The deployed support structure 141 provides support and stabilizes the vertebra column. Optionally, bone filler or therapeutic drugs may be inserted into the resident volume and around the support structure to stabilize the support structure and/or to promote bone fusion.
The distraction device 202 is preferably made from biocompatible materials that are suitable for long term implantation into human tissue in the treatment of degenerative tissue, trauma or metastatic conditions or where a tissue distraction device is needed. The material used may also be a biological material such as, Calcium Phosphate, Tricalicum Phosphate, Hydroxyapatite, or any other suitable biological material. The biocompatible materials may be PEEK (polyetheretherketone), Nylon, NiTi or any other suitable. The material may be solid or porous for tissue ingrowth, and may elute therapeutic or growth enhancing agents. One of the advantages of using biological or biocompatible material to treat vertebral compression fractures is that these elements have a more natural like substance. However, other materials could be used and still be within the scope of the present invention.
The guide wire 200 includes a proximal end portion 204 and a distal end portion 206. The distal end portion, in a deployed state, preferably defines a multi-tiered arrangement, scaffolding or platform, such as the illustrated coil or helical shape with a plurality of stacked windings, as shown in
A small knob 212 can be mounted at the proximal end portion 204 of the guide wire 200 to provide a gripping portion. The knob 212 can be held with one hand as the pusher 208 is advanced distally along the guide wire 200, indicated by arrow D in
It should therefore be apparent from the above that the present invention is particularly advantageous and conducive to minimally invasive surgical procedures for treatment of the spine. In accordance with this aspect of the present invention only a single access opening is required, which may be made transcutaneously and through the appropriate spinal bone or other tissue. Through this single opening a relatively large three-dimensional support structure can be built within the confined space of an individual vertebra or between adjoining vertebrae. Insertion of the distraction device may be aided by an introduction cannula or sheath, or the distraction device itself may be directly advanced through an access opening without the need for a cannula or other advancing aid. In any event, in the illustrated embodiment a relatively large support structure is built or formed in situ through a relatively much smaller access opening, providing the benefits of more drastic and invasive surgical approaches with the safety and ease of minimally invasive techniques.
As explained above, the guide wire 200 is preferably made of a shape memory material that has an initial or free state in the shape of a coil or spring. As the guide wire 200 is inserted into the cannula 224, the cannula constrains the guide wire into a generally elongated linear configuration, allowing an easy and minimally invasive deployment of the guide wire into the treatment site. Because of the shape memory properties, the guide wire 200 will return to its coil-shaped free state once the constraint is removed, i.e., as the guide wire exits the distal end portion 225 of the cannula 224 and enters the vertebral body 222. The guide wire 200 can be advanced through the cannula 224 manually or with the aid of an advancing mechanism, such as a ratcheting mechanism, e.g., the ratchet gun shown in
In order to improve the rate and ease of penetration of the guide wire 200 through bone and other tissues, an energy system can be operatively connected to the guide wire to transmit energy that enables the tip of the wire to drill through the tissue or bone to access the desired site or obtain the desire configuration. In the illustrated embodiment, the proximal end portion 204 of the guide wire 200 can be coupled to an energy system, such as a transducer assembly 226 with a piezoelectric element that produces ultrasonic vibrations at a specific frequency to help the guide wire penetrate the bony structure of the vertebral body. Such energy system could include an energy source 228 coupled to the transducer 226 capable of propagating ultrasonic energy at frequencies suitable for drilling a pathway into dense material, such as bone. The use of such energy systems that may be employed in the present invention are described in U.S. Pat. No. 6,498,421 to Oh which discloses drilling, U.S. Pat. No. 6,899,715 to Beaty which discloses boring and U.S. Pat. No. 4,838,853 to Parisi which discloses cutting using ultrasonic energy. Such devices have also been used in the vascular system to penetrate through arterial blood clots as described in U.S. Pat. No. 6,929,632 to Nita. All of the aforementioned patents are hereby incorporated herein by reference.
It will be understood that the energy system as described herein can also be used in a substantially similar manner to aid in the delivery of the above described distraction device 136 of
As the guide wire 200 exits the distal end portion 225 of the cannula 224 and enters the vertebral body 222, the distal end portion 206 of the guide wire begins to return to its unconstrained shape, i.e., the distal end portion of the guide wire begins to wind into its coil shape. Referring to
Referring to
One of the advantages of removing the introducer sheath and the cannula from the system is that such removal allows for a larger passageway into the vertebral body. The larger passageway makes it possible to employ distraction devices or implants having larger dimensions. Thus, when the introducer sheath and cannula are removed, the dimensions of the distraction device can be larger because the size of the distraction device is not constrained or controlled by the size of the introducer sheath or cannula. One advantage of employing a larger distraction device is that the larger distraction device provides a larger surface area that disperses the loading forces acting on the device and results in less pressure being placed on any given portion of the device or on the surface of the vertebral body contacted by the distraction device.
As illustrated in
Referring to
In the vertebral body, the distraction device 202 follows along the coiled shaped portion 206 of the guide wire 200 and winds into a coil shaped support structure 216 as shown in
One advantage of this embodiment of the distraction device, as noted above, is that it can be inserted through a small access hole and a much larger three dimensional support structure, such as a multi-tiered arrangement or scaffolding, can be built within a limited or confined space between or within the tissue layers. For instance the distraction device 202 can be inserted through a small access hole and the support structure 216 can be built one loop at the time by adding one thickness of the distraction device over another one. As an example, the average vertebral body is 18 mm in height. As illustrated in
After the distraction device 202 has been deployed, the guide wire 200 can be retracted from the distraction device and removed from the system. This can be accomplished by holding the pusher member 208 in place while retracting the guide wire 200 in a proximal direction. For example, the guide wire 200 can be retracted proximally by reversing the advancing mechanism, e.g., the ratchet mechanism of the delivery gun, while keeping the pusher member in place.
The distraction device of the present invention is preferably but not exclusively used with bone filler material to add stability to the distraction device and support between the distracted tissue, i.e., the endplates of the vertebra. Bone filler may be introduced in a variety of ways. As illustrated in
The distraction device may have a variety of configurations without departing from the present disclosure. The different configurations provide a variety of advantageous features of the distraction device. One aspect to be considered in regards to an implanted distraction device is the ability of the device to resist different forces, such as compressive and axial forces. It is easily understood that the device can resist compressive loading wherein the force on the distraction device is axial. However, additional lateral or translation forces can also act on the device when the body is moving.
In
In
In
In
In
In
In
In
The size and dimension of the distraction device when used for the treatment of vertebral compression fracture is preferably of a size that can be inserted through a cannula no larger that about a 6 gauge size (working diameter about 0.173 inches (about 4.39 mm)) which would allow the distraction device to have a generally square profile of about 0.118 inches×0.118 inches (about 3 mm×3 mm). Other sizes and dimensions could be used depending on the application. The length of the distraction device could be pre-determined or could be cut to fit during the treatment.
The construction of the distraction device could be accomplished using several techniques known in the art, including but not limited to molding, machining or extruding. It is also understood that the delivery coil or guide member could have different profiles and different shapes according to the application requirements.
In one embodiment, referring to
The distraction device also can be constructed by linking a plurality of individual distraction device elements together to form a chain-like structure. For example, a thin section of material could be connected to a plurality of cube-like distraction device elements to retain all of the elements together, forming a line or deformable linear structure. The individual distraction device elements can be similarly sized and shaped, or alternatively, each individual element can be a different size and shape.
Alternatively, the distraction device can be formed from a bar or rod shaped in which a multitude of slots that can be machined into the starting bar or rod at regular or random intervals. A channel may be bored through the middle of the distraction device for mounting and sliding onto a guide wire.
The distraction devices and guide wires of the present invention can be deployed by a variety of different methods and with a variety of apparatus. It will be understood that the deployment methods and apparatus disclosed in
The distraction device may be made more effective for certain procedures by using multiple coil or spring-shaped distraction devices in order to speed up the procedure and also increase the surface area in contact with the tissue or endplates in the case of treating vertebras. In circumstances where smaller distraction devices are used, but the surgeon desires to have the maximum surface area to support the two endplates of a vertebra, the surgeon can used a bi-transpedicular approach for instance as shown in
A double coil or distraction device having a superior device 268 and an inferior device 270 is also shown in
Another configuration of a double coil or device design is shown in
In order to both reduce delivery time and double the surface contact area, another distraction device configuration is illustrated with four distraction devices in
In addition to a manual pushrod advance of the distraction device, semi-automated or automated apparatus may be provided for ease of use.
Another device and method to deliver the distraction device are illustrated in
As noted above, the present invention relates to devices and methods to treat a condition that requires skin, tissue, organ, bone or a combination of those to be distracted from one another and supported apart of each other, either on a permanent situation or a temporary situation. It is also more specifically applicable for the treatment of vertebral compression fractures. The distraction device is also particularly well suited for the treatment of intervertebral disk treatments and spinal fusion.
Referring to
In one preferred method of delivering a distraction device in accordance with the present invention, referring to
As illustrated in
Once the distraction device has achieved the desired deployment, the delivery wire 316 can be removed leaving the support structure 313 in place as shown in
An alternate deployment method in accordance with the present invention is illustrated in
As illustrated in
After the distraction device 324a has formed the support structure 313a, if there are excess portions of the distraction device, the excess portion may be severed and removed. In other words, the distraction device can be cut to length after deployment. One of the advantages of being able to cut the distraction device to length is that a single distraction device is capable of being deployed over guide wires of different radii, lengths and coil or deployment configurations.
As shown in
The previous methods have been described for a posterior access to the spine. However, in some situations, especially in the lumbar region, an anterior approach is desired.
In the situation where the end plates of the adjacent vertebra are not parallel it may be preferable to use a distraction device that forms a support structure having oblique ends.
One advantage of an oblique configuration is that it can be used with a posterior approach as illustrated in
The distraction device having an oblique configuration can be formed from the distraction device ribbon 349 as illustrated in
The distraction devices of the present invention can also be used for total or partial vertebral body replacements (VBR). In one minimally invasive partial VBR procedure of the present invention, an endoscopic procedure, generally similar to the procedure described above with respect to
As the guide wire 404 exits the distal end portion 408 of the cannula 400 and enters the vertebral body 406, the distal end portion 410 of the guide wire begins to return to its unconstrained coiled shape. The guide wire 404 is advanced and deployed into the vertebral body until the coil shape reaches a desired height or has the desired number of windings 412.
After the guide wire 404 has achieved a desire deployment configuration, optionally, the cannula 400 can be retracted and removed from the system. At this stage, the coiled distal end portion 410 of the guide wire 404 is deployed within the vertebral body 406, and the proximal end portion 414 of the guide wire is extending out of the passageway 408. The proximal end portion 414 of the guide wire defines an insertion path for the distraction device 416, as illustrated in
The distraction device 416 is inserted over the proximal end portion 414 of the guide wire 404, and a pusher member 418 is placed over the guide wire behind or proximal the distraction device. As the pusher member 418 is advanced, it contacts the distraction device 416 and advances it forward or distally over the guide wire 404.
In the vertebral body, the distraction device 416 follows along the coiled shaped portion 410 of the guide wire 404 and winds into a coil shaped support structure 420. With each formation of an additional coil or winding 422 of the support structure 420, the support structure increases in height or extent. As the support structure 420 increases in height, it distracts and supports the endplates 424, 426 of the vertebra, restoring or partially restoring vertebral height and stabilizing the vertebral body 406.
After the distraction device 416 has been deployed, the guide wire 404 can be retracted from the distraction device and removed from the system. Alternatively, the guide wire 404 could be severed and left within the distraction device 416. Optionally, bone filler such as bone cement, allograph or autograph, or therapeutic drugs may be inserted in or around the device, by similar methods described above, in order stabilize the device and/or to promote bone fusion.
In one minimally invasive method of a total VBR procedure, the vertebral body removal tool described above can be used to remove substantially all of the vertebral body of a vertebra 401, and a disk removal tool can used to substantially remove the adjacent disks. Referring to
After the guide wire 404a has achieved a desired deployment configuration, the cannula 400a can be retracted and removed from the system. Referring to
After the distraction device has been deployed, optionally, bone filler, such as bone cement, allograph or autograph, or therapeutic drugs may be inserted in or around the support structure to stabilize the support structure and/or to promote bone fusion.
Although the present invention is described in light of the illustrated embodiments, it is understood that this for the purposes illustration and not limitation. Other applications, modifications or use of the support or distraction device may be made without departing for the scope of this invention, as set forth in the claims now or hereafter filed.
The present application is a continuation of co-pending U.S. patent application Ser. No. 12/705,895, filed Feb. 15, 2010, which is a continuation of U.S. patent application Ser. No. 11/464,790 which was filed on Aug. 15, 2006 and claims the benefit of U.S. Provisional Application Ser. No. 60/708,691, filed Aug. 16, 2005; U.S. Provisional Application Ser. No. 60/738,432, filed Nov. 21, 2005; and U.S. Provisional Application Ser. No. 60/784,185, filed Mar. 21, 2006, all of which are hereby incorporated herein by reference. The present application also incorporates herein by reference U.S. patent application Ser. Nos. 11/464,793; 11/464,782; 11/464,807; 11/464,815; and Ser. No. 11/464,812, all of which were filed on Aug. 15, 2006.
| Number | Name | Date | Kind |
|---|---|---|---|
| 1965653 | Kennedy | Jul 1934 | A |
| 3091237 | Skinner | May 1963 | A |
| 3112743 | Cochran et al. | Dec 1963 | A |
| 3648294 | Shahrestani | Mar 1972 | A |
| 3800788 | White | Apr 1974 | A |
| 3867728 | Stubstad et al. | Feb 1975 | A |
| 3875595 | Froning | Apr 1975 | A |
| 3889665 | Ling et al. | Jun 1975 | A |
| 3964480 | Froning | Jun 1976 | A |
| 4262676 | Jamshidi | Apr 1981 | A |
| 4274163 | Malcom et al. | Jun 1981 | A |
| 4312337 | Donohue | Jan 1982 | A |
| 4313434 | Segal | Feb 1982 | A |
| 4399814 | Pratt, Jr. et al. | Aug 1983 | A |
| 4462394 | Jacobs | Jul 1984 | A |
| 4466435 | Murray | Aug 1984 | A |
| 4467479 | Brody | Aug 1984 | A |
| 4488549 | Lee et al. | Dec 1984 | A |
| 4562598 | Kranz | Jan 1986 | A |
| 4595006 | Burke et al. | Jun 1986 | A |
| 4625722 | Murray | Dec 1986 | A |
| 4627434 | Murray | Dec 1986 | A |
| 4628945 | Johnson, Jr. | Dec 1986 | A |
| 4630616 | Tretinyak | Dec 1986 | A |
| 4665906 | Jervis | May 1987 | A |
| 4686973 | Frisch | Aug 1987 | A |
| 4697584 | Haynes | Oct 1987 | A |
| 4706670 | Andersen et al. | Nov 1987 | A |
| 4714478 | Fischer | Dec 1987 | A |
| 4743256 | Brantigan | May 1988 | A |
| 4772287 | Ray et al. | Sep 1988 | A |
| 4834069 | Umeda | May 1989 | A |
| 4838282 | Strasser et al. | Jun 1989 | A |
| 4863476 | Shepperd | Sep 1989 | A |
| 4878915 | Brantigan | Nov 1989 | A |
| 4888022 | Huebsch | Dec 1989 | A |
| 4888024 | Powlan | Dec 1989 | A |
| 4892550 | Huebsch | Jan 1990 | A |
| 4896662 | Noble | Jan 1990 | A |
| 4898577 | Badger et al. | Feb 1990 | A |
| 4904261 | Dove et al. | Feb 1990 | A |
| 4941466 | Romano | Jul 1990 | A |
| 4961740 | Ray et al. | Oct 1990 | A |
| 4969888 | Scholten et al. | Nov 1990 | A |
| 5015247 | Michelson | May 1991 | A |
| 5015255 | Kuslich | May 1991 | A |
| 5051189 | Farrah | Sep 1991 | A |
| 5053035 | McLaren | Oct 1991 | A |
| 5055104 | Ray | Oct 1991 | A |
| 5059193 | Kuslich | Oct 1991 | A |
| 5071435 | Fuchs et al. | Dec 1991 | A |
| 5098435 | Stednitz et al. | Mar 1992 | A |
| 5102413 | Poddar | Apr 1992 | A |
| 5108404 | Scholten et al. | Apr 1992 | A |
| 5122130 | Keller | Jun 1992 | A |
| 5123926 | Pisharodi | Jun 1992 | A |
| 5147366 | Arroyo et al. | Sep 1992 | A |
| 5163989 | Campbell et al. | Nov 1992 | A |
| 5171280 | Baumgartner | Dec 1992 | A |
| 5176683 | Kimsey et al. | Jan 1993 | A |
| 5176692 | Wilk et al. | Jan 1993 | A |
| 5183052 | Terwilliger | Feb 1993 | A |
| 5192327 | Brantigan | Mar 1993 | A |
| 5228441 | Lundquist | Jul 1993 | A |
| 5242448 | Pettine et al. | Sep 1993 | A |
| 5242879 | Abe et al. | Sep 1993 | A |
| 5257632 | Turkel et al. | Nov 1993 | A |
| 5263953 | Bagby | Nov 1993 | A |
| 5285795 | Ryan et al. | Feb 1994 | A |
| 5303718 | Krajicek | Apr 1994 | A |
| 5306308 | Gross et al. | Apr 1994 | A |
| 5306310 | Siebels | Apr 1994 | A |
| 5322505 | Krause et al. | Jun 1994 | A |
| 5330429 | Noguchi et al. | Jul 1994 | A |
| 5331975 | Bonutti | Jul 1994 | A |
| 5361752 | Moll et al. | Nov 1994 | A |
| 5383932 | Wilson et al. | Jan 1995 | A |
| 5385151 | Scarfone et al. | Jan 1995 | A |
| 5423816 | Lin | Jun 1995 | A |
| 5423817 | Lin | Jun 1995 | A |
| 5423850 | Berger | Jun 1995 | A |
| 5431658 | Moskovich | Jul 1995 | A |
| 5441538 | Bonutti | Aug 1995 | A |
| 5454365 | Bonutti | Oct 1995 | A |
| 5454827 | Aust et al. | Oct 1995 | A |
| 5456686 | Klapper et al. | Oct 1995 | A |
| 5462563 | Shearer et al. | Oct 1995 | A |
| 5468245 | Vargas, III | Nov 1995 | A |
| 5480400 | Berger | Jan 1996 | A |
| 5484437 | Michelson | Jan 1996 | A |
| 5509923 | Middleman et al. | Apr 1996 | A |
| 5514143 | Bonutti et al. | May 1996 | A |
| 5514153 | Bonutti | May 1996 | A |
| 5522398 | Goldenberg et al. | Jun 1996 | A |
| 5522790 | Moll et al. | Jun 1996 | A |
| 5522846 | Bonutti | Jun 1996 | A |
| 5527343 | Bonutti | Jun 1996 | A |
| 5527624 | Higgins et al. | Jun 1996 | A |
| 5531856 | Moll et al. | Jul 1996 | A |
| 5534023 | Henley | Jul 1996 | A |
| 5538009 | Byrne et al. | Jul 1996 | A |
| 5540711 | Kieturakis et al. | Jul 1996 | A |
| 5545222 | Bonutti | Aug 1996 | A |
| 5549679 | Kuslich | Aug 1996 | A |
| 5562736 | Ray et al. | Oct 1996 | A |
| 5571109 | Bertagnoli | Nov 1996 | A |
| 5571189 | Kuslich | Nov 1996 | A |
| 5571190 | Ulrich et al. | Nov 1996 | A |
| 5575790 | Chen et al. | Nov 1996 | A |
| 5593409 | Michelson | Jan 1997 | A |
| 5601556 | Pisharodi | Feb 1997 | A |
| 5601572 | Middleman et al. | Feb 1997 | A |
| 5632746 | Middleman et al. | May 1997 | A |
| 5645597 | Krapiva | Jul 1997 | A |
| 5665122 | Kambin | Sep 1997 | A |
| 5669926 | Aust et al. | Sep 1997 | A |
| 5674295 | Ray et al. | Oct 1997 | A |
| 5681263 | Flesch | Oct 1997 | A |
| 5693100 | Pisharodi | Dec 1997 | A |
| 5695513 | Johnson et al. | Dec 1997 | A |
| 5700239 | Yoon | Dec 1997 | A |
| 5702453 | Rabbe et al. | Dec 1997 | A |
| 5702454 | Baumgartner | Dec 1997 | A |
| 5716416 | Lin | Feb 1998 | A |
| 5741253 | Michelson | Apr 1998 | A |
| 5749879 | Middleman et al. | May 1998 | A |
| 5755797 | Baumgartner | May 1998 | A |
| 5756127 | Grisoni et al. | May 1998 | A |
| 5766252 | Henry | Jun 1998 | A |
| 5772661 | Michelson | Jun 1998 | A |
| 5782832 | Larsen et al. | Jul 1998 | A |
| 5788703 | Mittelmeier et al. | Aug 1998 | A |
| 5807275 | Jamshidi | Sep 1998 | A |
| 5820628 | Middleman et al. | Oct 1998 | A |
| 5823979 | Mezo | Oct 1998 | A |
| 5824093 | Ray et al. | Oct 1998 | A |
| 5827289 | Reiley et al. | Oct 1998 | A |
| 5836948 | Zucherman et al. | Nov 1998 | A |
| 5848986 | Lundquist et al. | Dec 1998 | A |
| 5851212 | Zirps et al. | Dec 1998 | A |
| 5860977 | Zucherman et al. | Jan 1999 | A |
| 5865848 | Baker | Feb 1999 | A |
| 5904690 | Middleman et al. | May 1999 | A |
| 5919235 | Husson et al. | Jul 1999 | A |
| 5925074 | Gingras et al. | Jul 1999 | A |
| 5961554 | Janson et al. | Oct 1999 | A |
| 5972015 | Scribner et al. | Oct 1999 | A |
| 5976186 | Bao et al. | Nov 1999 | A |
| 5980522 | Koros et al. | Nov 1999 | A |
| 6012494 | Balazs | Jan 2000 | A |
| 6015436 | Schonhoffer | Jan 2000 | A |
| 6019793 | Perren et al. | Feb 2000 | A |
| 6030401 | Marino | Feb 2000 | A |
| 6033406 | Mathews | Mar 2000 | A |
| 6033412 | Losken et al. | Mar 2000 | A |
| 6039740 | Olerud | Mar 2000 | A |
| 6039761 | Li | Mar 2000 | A |
| 6045552 | Zucherman et al. | Apr 2000 | A |
| 6048342 | Zucherman et al. | Apr 2000 | A |
| 6048346 | Reiley et al. | Apr 2000 | A |
| 6048360 | Khosravi et al. | Apr 2000 | A |
| 6066154 | Reiley et al. | May 2000 | A |
| 6068630 | Zucherman et al. | May 2000 | A |
| 6073051 | Sharkey et al. | Jun 2000 | A |
| 6083225 | Winslow et al. | Jul 2000 | A |
| 6090143 | Meriwether et al. | Jul 2000 | A |
| 6096080 | Nicholson | Aug 2000 | A |
| 6102950 | Vaccaro | Aug 2000 | A |
| 6110210 | Norton et al. | Aug 2000 | A |
| 6113640 | Tormala et al. | Sep 2000 | A |
| 6119044 | Kuzma | Sep 2000 | A |
| 6123705 | Michelson | Sep 2000 | A |
| 6126660 | Dietz | Oct 2000 | A |
| 6127597 | Beyar et al. | Oct 2000 | A |
| 6159211 | Boriani et al. | Dec 2000 | A |
| 6159244 | Suddaby | Dec 2000 | A |
| 6165218 | Husson et al. | Dec 2000 | A |
| 6174337 | Keenan | Jan 2001 | B1 |
| 6179873 | Zientek | Jan 2001 | B1 |
| 6187048 | Milner et al. | Feb 2001 | B1 |
| 6190414 | Young et al. | Feb 2001 | B1 |
| 6193757 | Foley et al. | Feb 2001 | B1 |
| 6197033 | Haid, Jr. et al. | Mar 2001 | B1 |
| D439980 | Reiley et al. | Apr 2001 | S |
| 6217579 | Koros | Apr 2001 | B1 |
| 6221082 | Marino et al. | Apr 2001 | B1 |
| 6224603 | Marino | May 2001 | B1 |
| 6235030 | Zucherman et al. | May 2001 | B1 |
| 6235043 | Reiley et al. | May 2001 | B1 |
| 6238491 | Davidson et al. | May 2001 | B1 |
| 6241734 | Scribner et al. | Jun 2001 | B1 |
| 6248110 | Reiley et al. | Jun 2001 | B1 |
| 6251140 | Marino et al. | Jun 2001 | B1 |
| 6261289 | Levy | Jul 2001 | B1 |
| 6264695 | Stoy | Jul 2001 | B1 |
| 6267763 | Castro | Jul 2001 | B1 |
| 6280456 | Scribner et al. | Aug 2001 | B1 |
| 6280475 | Bao et al. | Aug 2001 | B1 |
| 6290724 | Marino | Sep 2001 | B1 |
| D449691 | Reiley et al. | Oct 2001 | S |
| 6296647 | Robioneck et al. | Oct 2001 | B1 |
| 6312443 | Stone | Nov 2001 | B1 |
| 6364828 | Yeung et al. | Apr 2002 | B1 |
| 6368325 | McKinley et al. | Apr 2002 | B1 |
| 6387130 | Stone et al. | May 2002 | B1 |
| 6402750 | Atkinson et al. | Jun 2002 | B1 |
| 6419641 | Mark et al. | Jul 2002 | B1 |
| 6419705 | Erickson | Jul 2002 | B1 |
| 6423071 | Lawson | Jul 2002 | B1 |
| 6423083 | Reiley et al. | Jul 2002 | B2 |
| 6423089 | Gingras et al. | Jul 2002 | B1 |
| 6425887 | McGuckin et al. | Jul 2002 | B1 |
| 6425919 | Lambrecht | Jul 2002 | B1 |
| 6428541 | Boyd et al. | Aug 2002 | B1 |
| 6436140 | Liu et al. | Aug 2002 | B1 |
| 6440138 | Reiley et al. | Aug 2002 | B1 |
| 6451019 | Zucherman et al. | Sep 2002 | B1 |
| 6468279 | Reo | Oct 2002 | B1 |
| 6478805 | Marino et al. | Nov 2002 | B1 |
| 6482235 | Lambrecht et al. | Nov 2002 | B1 |
| 6485518 | Cornwall et al. | Nov 2002 | B1 |
| D467657 | Scribner | Dec 2002 | S |
| 6488710 | Besselink | Dec 2002 | B2 |
| 6491626 | Stone et al. | Dec 2002 | B1 |
| 6491695 | Roggenbuck | Dec 2002 | B1 |
| 6498421 | Oh et al. | Dec 2002 | B1 |
| 6500178 | Zucherman et al. | Dec 2002 | B2 |
| 6500205 | Michelson | Dec 2002 | B1 |
| 6508839 | Lambrecht et al. | Jan 2003 | B1 |
| 6511471 | Rosenman et al. | Jan 2003 | B2 |
| 6512958 | Swoyer et al. | Jan 2003 | B1 |
| D469871 | Sand | Feb 2003 | S |
| 6520991 | Huene | Feb 2003 | B2 |
| D472323 | Sand | Mar 2003 | S |
| 6530930 | Marino et al. | Mar 2003 | B1 |
| 6533791 | Betz et al. | Mar 2003 | B1 |
| 6533797 | Stone et al. | Mar 2003 | B1 |
| 6540747 | Marino | Apr 2003 | B1 |
| 6554833 | Levy et al. | Apr 2003 | B2 |
| 6558390 | Cragg | May 2003 | B2 |
| 6562074 | Gerbec et al. | May 2003 | B2 |
| 6575919 | Reiley et al. | Jun 2003 | B1 |
| 6575979 | Cragg | Jun 2003 | B1 |
| 6576016 | Hochshuler et al. | Jun 2003 | B1 |
| 6579291 | Keith et al. | Jun 2003 | B1 |
| 6582431 | Ray | Jun 2003 | B1 |
| 6582433 | Yun | Jun 2003 | B2 |
| 6595998 | Johnson et al. | Jul 2003 | B2 |
| 6599294 | Fuss et al. | Jul 2003 | B2 |
| 6602293 | Biermann et al. | Aug 2003 | B1 |
| 6607530 | Carl et al. | Aug 2003 | B1 |
| 6607544 | Boucher et al. | Aug 2003 | B1 |
| 6610094 | Husson | Aug 2003 | B2 |
| 6613054 | Scribner et al. | Sep 2003 | B2 |
| 6620196 | Trieu | Sep 2003 | B1 |
| 6623505 | Scribner et al. | Sep 2003 | B2 |
| D482787 | Reiss | Nov 2003 | S |
| 6641587 | Scribner et al. | Nov 2003 | B2 |
| 6645213 | Sand et al. | Nov 2003 | B2 |
| 6648917 | Gerbec et al. | Nov 2003 | B2 |
| D483495 | Sand | Dec 2003 | S |
| 6656178 | Veldhuizen et al. | Dec 2003 | B1 |
| 6656180 | Stahurski | Dec 2003 | B2 |
| 6660037 | Husson et al. | Dec 2003 | B1 |
| 6663647 | Reiley et al. | Dec 2003 | B2 |
| 6666890 | Michelson | Dec 2003 | B2 |
| 6666891 | Boehm, Jr. et al. | Dec 2003 | B2 |
| 6676663 | Higueras et al. | Jan 2004 | B2 |
| 6676665 | Foley et al. | Jan 2004 | B2 |
| 6682561 | Songer et al. | Jan 2004 | B2 |
| 6685742 | Jackson | Feb 2004 | B1 |
| 6689125 | Keith et al. | Feb 2004 | B1 |
| 6689168 | Lieberman | Feb 2004 | B2 |
| 6692563 | Zimmermann | Feb 2004 | B2 |
| 6706070 | Wagner et al. | Mar 2004 | B1 |
| 6716216 | Boucher et al. | Apr 2004 | B1 |
| 6716247 | Michelson | Apr 2004 | B2 |
| 6716957 | Tunc | Apr 2004 | B2 |
| 6719761 | Reiley et al. | Apr 2004 | B1 |
| 6719773 | Boucher et al. | Apr 2004 | B1 |
| 6723128 | Uk | Apr 2004 | B2 |
| 6726691 | Osorio et al. | Apr 2004 | B2 |
| D490159 | Sand | May 2004 | S |
| 6740093 | Hochschuler et al. | May 2004 | B2 |
| D492032 | Muller et al. | Jun 2004 | S |
| 6749560 | Konstorum et al. | Jun 2004 | B1 |
| 6755841 | Fraser et al. | Jun 2004 | B2 |
| D492775 | Doelling et al. | Jul 2004 | S |
| D493533 | Blain | Jul 2004 | S |
| 6758673 | Fromovich et al. | Jul 2004 | B2 |
| 6764514 | Li et al. | Jul 2004 | B1 |
| D495417 | Doelling et al. | Aug 2004 | S |
| 6773460 | Jackson | Aug 2004 | B2 |
| 6780151 | Grabover et al. | Aug 2004 | B2 |
| 6783530 | Levy | Aug 2004 | B1 |
| 6793679 | Michelson | Sep 2004 | B2 |
| 6796983 | Zucherman et al. | Sep 2004 | B1 |
| 6805695 | Keith et al. | Oct 2004 | B2 |
| 6805697 | Helm et al. | Oct 2004 | B1 |
| 6808537 | Michelson | Oct 2004 | B2 |
| 6814736 | Reiley et al. | Nov 2004 | B2 |
| 6814756 | Michelson | Nov 2004 | B1 |
| 6821298 | Jackson | Nov 2004 | B1 |
| 6830589 | Erickson | Dec 2004 | B2 |
| 6835205 | Atkinson et al. | Dec 2004 | B2 |
| 6835206 | Jackson | Dec 2004 | B2 |
| 6840944 | Suddaby | Jan 2005 | B2 |
| 6852126 | Ahlgren | Feb 2005 | B2 |
| 6852129 | Gerbec et al. | Feb 2005 | B2 |
| 6863668 | Gillespie et al. | Mar 2005 | B2 |
| 6863672 | Reiley et al. | Mar 2005 | B2 |
| 6863673 | Gerbec et al. | Mar 2005 | B2 |
| 6866682 | An et al. | Mar 2005 | B1 |
| 6881228 | Zdeblick et al. | Apr 2005 | B2 |
| 6883520 | Lambrecht et al. | Apr 2005 | B2 |
| 6887248 | McKinley et al. | May 2005 | B2 |
| 6893466 | Trieu | May 2005 | B2 |
| 6899716 | Cragg | May 2005 | B2 |
| 6899719 | Reiley et al. | May 2005 | B2 |
| D506828 | Layne et al. | Jun 2005 | S |
| 6905512 | Paes et al. | Jun 2005 | B2 |
| 6908506 | Zimmermann | Jun 2005 | B2 |
| 6921403 | Cragg et al. | Jul 2005 | B2 |
| 6923810 | Michelson | Aug 2005 | B1 |
| 6923813 | Phillips et al. | Aug 2005 | B2 |
| 6923814 | Hildebrand et al. | Aug 2005 | B1 |
| 6929647 | Cohen | Aug 2005 | B2 |
| 6945973 | Bray | Sep 2005 | B2 |
| 6952129 | Lin et al. | Oct 2005 | B2 |
| 6962606 | Michelson | Nov 2005 | B2 |
| 6964674 | Matsuura et al. | Nov 2005 | B1 |
| D512506 | Layne et al. | Dec 2005 | S |
| 6972035 | Michelson | Dec 2005 | B2 |
| 6974479 | Trieu | Dec 2005 | B2 |
| 6979341 | Scribner et al. | Dec 2005 | B2 |
| 6981981 | Reiley et al. | Jan 2006 | B2 |
| 6997929 | Manzi et al. | Feb 2006 | B2 |
| 7004945 | Boyd et al. | Feb 2006 | B2 |
| 7008453 | Michelson | Mar 2006 | B1 |
| 7014633 | Cragg | Mar 2006 | B2 |
| 7018089 | Wenz et al. | Mar 2006 | B2 |
| 7018415 | McKay | Mar 2006 | B1 |
| 7018453 | Klein et al. | Mar 2006 | B2 |
| 7029498 | Boehm et al. | Apr 2006 | B2 |
| 7044954 | Reiley et al. | May 2006 | B2 |
| 7048694 | Mark et al. | May 2006 | B2 |
| 7063703 | Reo | Jun 2006 | B2 |
| 7066961 | Michelson | Jun 2006 | B2 |
| 7069087 | Sharkey et al. | Jun 2006 | B2 |
| 7070598 | Lim et al. | Jul 2006 | B2 |
| 7074226 | Roehm, III et al. | Jul 2006 | B2 |
| 7081120 | Li et al. | Jul 2006 | B2 |
| 7081122 | Reiley et al. | Jul 2006 | B1 |
| 7087055 | Lim et al. | Aug 2006 | B2 |
| 7094257 | Mujwid et al. | Aug 2006 | B2 |
| 7115128 | Michelson | Oct 2006 | B2 |
| 7115163 | Zimmermann | Oct 2006 | B2 |
| 7118579 | Michelson | Oct 2006 | B2 |
| 7118580 | Beyersdorff et al. | Oct 2006 | B1 |
| 7118598 | Michelson | Oct 2006 | B2 |
| 7124761 | Lambrecht et al. | Oct 2006 | B2 |
| 7128760 | Michelson | Oct 2006 | B2 |
| 7135424 | Worley et al. | Nov 2006 | B2 |
| 7153304 | Robie et al. | Dec 2006 | B2 |
| 7153305 | Johnson | Dec 2006 | B2 |
| 7153306 | Ralph et al. | Dec 2006 | B2 |
| 7153307 | Scribner et al. | Dec 2006 | B2 |
| 7156874 | Paponneau et al. | Jan 2007 | B2 |
| 7156875 | Michelson | Jan 2007 | B2 |
| 7166107 | Anderson | Jan 2007 | B2 |
| 7179293 | McKay | Feb 2007 | B2 |
| 7189242 | Boyd et al. | Mar 2007 | B2 |
| 7204851 | Trieu et al. | Apr 2007 | B2 |
| 7207991 | Michelson | Apr 2007 | B2 |
| 7211112 | Baynham et al. | May 2007 | B2 |
| 7214227 | Colleran et al. | May 2007 | B2 |
| 7220281 | Lambrecht et al. | May 2007 | B2 |
| 7223227 | Pflueger | May 2007 | B2 |
| 7226481 | Kuslich | Jun 2007 | B2 |
| 7241297 | Shaolian et al. | Jul 2007 | B2 |
| 7244273 | Pedersen et al. | Jul 2007 | B2 |
| 7250060 | Trieu | Jul 2007 | B2 |
| 7252671 | Scribner et al. | Aug 2007 | B2 |
| 7267687 | McGuckin, Jr. | Sep 2007 | B2 |
| 7270679 | Istephanous et al. | Sep 2007 | B2 |
| 7276062 | McDaniel et al. | Oct 2007 | B2 |
| 7311713 | Johnson et al. | Dec 2007 | B2 |
| 7316714 | Gordon et al. | Jan 2008 | B2 |
| 7318840 | McKay | Jan 2008 | B2 |
| 7320689 | Keller | Jan 2008 | B2 |
| 7322962 | Forrest | Jan 2008 | B2 |
| 7383639 | Malandain | Jun 2008 | B2 |
| 7485134 | Simonson | Feb 2009 | B2 |
| 7608083 | Lee et al. | Oct 2009 | B2 |
| 7637905 | Saadat et al. | Dec 2009 | B2 |
| 7828807 | LeHuec et al. | Nov 2010 | B2 |
| 8187327 | Edidin et al. | May 2012 | B2 |
| 8236029 | Siegal | Aug 2012 | B2 |
| 20010011174 | Reiley et al. | Aug 2001 | A1 |
| 20010016741 | Burkus et al. | Aug 2001 | A1 |
| 20010049531 | Reiley | Dec 2001 | A1 |
| 20020016583 | Cragg | Feb 2002 | A1 |
| 20020026195 | Layne et al. | Feb 2002 | A1 |
| 20020026244 | Trieu | Feb 2002 | A1 |
| 20020045942 | Ham | Apr 2002 | A1 |
| 20020068974 | Kuslich et al. | Jun 2002 | A1 |
| 20020077700 | Varga et al. | Jun 2002 | A1 |
| 20020082584 | Rosenman et al. | Jun 2002 | A1 |
| 20020082608 | Reiley et al. | Jun 2002 | A1 |
| 20020087163 | Dixon et al. | Jul 2002 | A1 |
| 20020091390 | Michelson | Jul 2002 | A1 |
| 20020099385 | Ralph et al. | Jul 2002 | A1 |
| 20020107519 | Dixon et al. | Aug 2002 | A1 |
| 20020107573 | Steinberg | Aug 2002 | A1 |
| 20020156482 | Scribner et al. | Oct 2002 | A1 |
| 20020169471 | Ferdinand | Nov 2002 | A1 |
| 20020172851 | Corey et al. | Nov 2002 | A1 |
| 20020173796 | Cragg | Nov 2002 | A1 |
| 20020173841 | Ortiz et al. | Nov 2002 | A1 |
| 20020173851 | McKay | Nov 2002 | A1 |
| 20020183761 | Johnson | Dec 2002 | A1 |
| 20020183778 | Reiley et al. | Dec 2002 | A1 |
| 20020191487 | Sand | Dec 2002 | A1 |
| 20030018390 | Husson | Jan 2003 | A1 |
| 20030032963 | Reiss et al. | Feb 2003 | A1 |
| 20030040796 | Ferree | Feb 2003 | A1 |
| 20030045937 | Ginn | Mar 2003 | A1 |
| 20030050644 | Boucher et al. | Mar 2003 | A1 |
| 20030069593 | Tremulis et al. | Apr 2003 | A1 |
| 20030074075 | Thomas, Jr. | Apr 2003 | A1 |
| 20030108588 | Chen et al. | Jun 2003 | A1 |
| 20030130664 | Boucher | Jul 2003 | A1 |
| 20030171812 | Grunberg et al. | Sep 2003 | A1 |
| 20030187445 | Keith et al. | Oct 2003 | A1 |
| 20030191414 | Reiley et al. | Oct 2003 | A1 |
| 20030191489 | Reiley et al. | Oct 2003 | A1 |
| 20030195518 | Cragg | Oct 2003 | A1 |
| 20030195547 | Scribner et al. | Oct 2003 | A1 |
| 20030195630 | Ferree | Oct 2003 | A1 |
| 20030199979 | McGuckin, Jr. | Oct 2003 | A1 |
| 20030208136 | Mark et al. | Nov 2003 | A1 |
| 20030220648 | Osorio et al. | Nov 2003 | A1 |
| 20030220695 | Sevrain | Nov 2003 | A1 |
| 20030229372 | Reiley et al. | Dec 2003 | A1 |
| 20030233096 | Osorio et al. | Dec 2003 | A1 |
| 20030233146 | Grinberg | Dec 2003 | A1 |
| 20040010251 | Pitaru et al. | Jan 2004 | A1 |
| 20040010260 | Scribner et al. | Jan 2004 | A1 |
| 20040010263 | Boucher et al. | Jan 2004 | A1 |
| 20040019354 | Johnson et al. | Jan 2004 | A1 |
| 20040024408 | Burkus et al. | Feb 2004 | A1 |
| 20040024409 | Sand et al. | Feb 2004 | A1 |
| 20040024463 | Thomas, Jr. et al. | Feb 2004 | A1 |
| 20040024465 | Lambrecht et al. | Feb 2004 | A1 |
| 20040034343 | Gillespie et al. | Feb 2004 | A1 |
| 20040034429 | Lambrecht et al. | Feb 2004 | A1 |
| 20040049203 | Scribner et al. | Mar 2004 | A1 |
| 20040059333 | Carl | Mar 2004 | A1 |
| 20040059339 | Roehm, III et al. | Mar 2004 | A1 |
| 20040059418 | McKay et al. | Mar 2004 | A1 |
| 20040064144 | Johnson | Apr 2004 | A1 |
| 20040073308 | Kuslich et al. | Apr 2004 | A1 |
| 20040082953 | Petit | Apr 2004 | A1 |
| 20040087947 | Lim et al. | May 2004 | A1 |
| 20040092933 | Shaolian et al. | May 2004 | A1 |
| 20040092948 | Stevens et al. | May 2004 | A1 |
| 20040092988 | Shaolian et al. | May 2004 | A1 |
| 20040097924 | Lambrecht et al. | May 2004 | A1 |
| 20040097930 | Justis et al. | May 2004 | A1 |
| 20040097932 | Ray, III et al. | May 2004 | A1 |
| 20040098131 | Bryan et al. | May 2004 | A1 |
| 20040102774 | Trieu | May 2004 | A1 |
| 20040106940 | Shaolian et al. | Jun 2004 | A1 |
| 20040111161 | Trieu | Jun 2004 | A1 |
| 20040117019 | Trieu et al. | Jun 2004 | A1 |
| 20040133124 | Bates et al. | Jul 2004 | A1 |
| 20040133229 | Lambrecht et al. | Jul 2004 | A1 |
| 20040133280 | Trieu | Jul 2004 | A1 |
| 20040138748 | Boyer, II et al. | Jul 2004 | A1 |
| 20040153064 | Foley et al. | Aug 2004 | A1 |
| 20040153115 | Reiley et al. | Aug 2004 | A1 |
| 20040158206 | Aboul-Hosn et al. | Aug 2004 | A1 |
| 20040167561 | Boucher et al. | Aug 2004 | A1 |
| 20040167562 | Osorio et al. | Aug 2004 | A1 |
| 20040167625 | Beyar et al. | Aug 2004 | A1 |
| 20040176775 | Burkus et al. | Sep 2004 | A1 |
| 20040186471 | Trieu | Sep 2004 | A1 |
| 20040186528 | Ries et al. | Sep 2004 | A1 |
| 20040186573 | Ferree | Sep 2004 | A1 |
| 20040210231 | Boucher et al. | Oct 2004 | A1 |
| 20040210310 | Trieu | Oct 2004 | A1 |
| 20040215344 | Hochschuler et al. | Oct 2004 | A1 |
| 20040220580 | Johnson et al. | Nov 2004 | A1 |
| 20040220672 | Shadduck | Nov 2004 | A1 |
| 20040225296 | Reiss et al. | Nov 2004 | A1 |
| 20040225361 | Glenn et al. | Nov 2004 | A1 |
| 20040230191 | Frey et al. | Nov 2004 | A1 |
| 20040230309 | DiMauro | Nov 2004 | A1 |
| 20040243229 | Vidlund et al. | Dec 2004 | A1 |
| 20040243241 | Istephanous | Dec 2004 | A1 |
| 20040249377 | Kaes et al. | Dec 2004 | A1 |
| 20040254520 | Porteous et al. | Dec 2004 | A1 |
| 20040254644 | Taylor | Dec 2004 | A1 |
| 20040260300 | Gorensek et al. | Dec 2004 | A1 |
| 20040260397 | Lambrecht et al. | Dec 2004 | A1 |
| 20040267271 | Scribner et al. | Dec 2004 | A9 |
| 20050004578 | Lambrecht et al. | Jan 2005 | A1 |
| 20050010293 | Zucherman et al. | Jan 2005 | A1 |
| 20050010298 | Zucherman et al. | Jan 2005 | A1 |
| 20050015148 | Jansen et al. | Jan 2005 | A1 |
| 20050015152 | Sweeney | Jan 2005 | A1 |
| 20050021041 | Michelson | Jan 2005 | A1 |
| 20050033295 | Wisnewski | Feb 2005 | A1 |
| 20050033440 | Lambrecht et al. | Feb 2005 | A1 |
| 20050038517 | Carrison et al. | Feb 2005 | A1 |
| 20050043737 | Reiley et al. | Feb 2005 | A1 |
| 20050043796 | Grant et al. | Feb 2005 | A1 |
| 20050054948 | Goldenberg | Mar 2005 | A1 |
| 20050055097 | Grunberg et al. | Mar 2005 | A1 |
| 20050060036 | Schultz et al. | Mar 2005 | A1 |
| 20050060038 | Lambrecht et al. | Mar 2005 | A1 |
| 20050065519 | Michelson | Mar 2005 | A1 |
| 20050065609 | Wardlaw | Mar 2005 | A1 |
| 20050069571 | Slivka et al. | Mar 2005 | A1 |
| 20050070908 | Cragg | Mar 2005 | A1 |
| 20050070911 | Carrison | Mar 2005 | A1 |
| 20050070913 | Milbocker et al. | Mar 2005 | A1 |
| 20050071011 | Ralph et al. | Mar 2005 | A1 |
| 20050080488 | Schultz | Apr 2005 | A1 |
| 20050085912 | Arnin et al. | Apr 2005 | A1 |
| 20050090833 | DiPoto | Apr 2005 | A1 |
| 20050090852 | Layne et al. | Apr 2005 | A1 |
| 20050090899 | DiPoto | Apr 2005 | A1 |
| 20050107880 | Shimp et al. | May 2005 | A1 |
| 20050113918 | Messerli et al. | May 2005 | A1 |
| 20050113919 | Cragg et al. | May 2005 | A1 |
| 20050113928 | Cragg et al. | May 2005 | A1 |
| 20050118228 | Trieu | Jun 2005 | A1 |
| 20050119662 | Reiley et al. | Jun 2005 | A1 |
| 20050119750 | Studer | Jun 2005 | A1 |
| 20050119751 | Lawson | Jun 2005 | A1 |
| 20050119752 | Williams et al. | Jun 2005 | A1 |
| 20050119754 | Trieu et al. | Jun 2005 | A1 |
| 20050124989 | Suddaby | Jun 2005 | A1 |
| 20050124992 | Ferree | Jun 2005 | A1 |
| 20050124999 | Teitelbaum et al. | Jun 2005 | A1 |
| 20050125066 | McAfee | Jun 2005 | A1 |
| 20050131267 | Talmadge | Jun 2005 | A1 |
| 20050131268 | Talmadge | Jun 2005 | A1 |
| 20050131269 | Talmadge | Jun 2005 | A1 |
| 20050131536 | Eisermann et al. | Jun 2005 | A1 |
| 20050131540 | Trieu | Jun 2005 | A1 |
| 20050131541 | Trieu | Jun 2005 | A1 |
| 20050137602 | Assell et al. | Jun 2005 | A1 |
| 20050142211 | Wenz | Jun 2005 | A1 |
| 20050143763 | Ortiz et al. | Jun 2005 | A1 |
| 20050143827 | Globerman et al. | Jun 2005 | A1 |
| 20050149022 | Shaolian et al. | Jul 2005 | A1 |
| 20050149191 | Cragg et al. | Jul 2005 | A1 |
| 20050149194 | Ahlgren | Jul 2005 | A1 |
| 20050149197 | Cauthen | Jul 2005 | A1 |
| 20050154396 | Foley et al. | Jul 2005 | A1 |
| 20050154463 | Trieu | Jul 2005 | A1 |
| 20050165406 | Assell et al. | Jul 2005 | A1 |
| 20050171539 | Braun et al. | Aug 2005 | A1 |
| 20050171552 | Johnson et al. | Aug 2005 | A1 |
| 20050182412 | Johnson et al. | Aug 2005 | A1 |
| 20050182413 | Johnson et al. | Aug 2005 | A1 |
| 20050182414 | Manzi et al. | Aug 2005 | A1 |
| 20050187556 | Stack et al. | Aug 2005 | A1 |
| 20050187558 | Johnson et al. | Aug 2005 | A1 |
| 20050187559 | Raymond et al. | Aug 2005 | A1 |
| 20050187564 | Jayaraman | Aug 2005 | A1 |
| 20050197707 | Trieu et al. | Sep 2005 | A1 |
| 20050216018 | Sennett | Sep 2005 | A1 |
| 20050216087 | Zucherman et al. | Sep 2005 | A1 |
| 20050222684 | Ferree | Oct 2005 | A1 |
| 20050228383 | Zucherman et al. | Oct 2005 | A1 |
| 20050228391 | Levy et al. | Oct 2005 | A1 |
| 20050228397 | Malandain et al. | Oct 2005 | A1 |
| 20050234425 | Miller et al. | Oct 2005 | A1 |
| 20050234451 | Markworth | Oct 2005 | A1 |
| 20050234452 | Malandain | Oct 2005 | A1 |
| 20050234456 | Malandain | Oct 2005 | A1 |
| 20050240182 | Zucherman et al. | Oct 2005 | A1 |
| 20050240189 | Rousseau et al. | Oct 2005 | A1 |
| 20050240193 | Layne et al. | Oct 2005 | A1 |
| 20050240269 | Lambrecht et al. | Oct 2005 | A1 |
| 20050251149 | Wenz | Nov 2005 | A1 |
| 20050251260 | Gerber et al. | Nov 2005 | A1 |
| 20050261684 | Shaolian et al. | Nov 2005 | A1 |
| 20050261695 | Cragg et al. | Nov 2005 | A1 |
| 20050261781 | Sennett et al. | Nov 2005 | A1 |
| 20050267471 | Biedermann | Dec 2005 | A1 |
| 20050273166 | Sweeney | Dec 2005 | A1 |
| 20050273173 | Gordon | Dec 2005 | A1 |
| 20050278023 | Zwirkoski | Dec 2005 | A1 |
| 20050278027 | Hyde, Jr. | Dec 2005 | A1 |
| 20050278029 | Trieu | Dec 2005 | A1 |
| 20050283244 | Gordon et al. | Dec 2005 | A1 |
| 20050287071 | Wenz | Dec 2005 | A1 |
| 20060004456 | McKay | Jan 2006 | A1 |
| 20060009779 | Collins et al. | Jan 2006 | A1 |
| 20060030850 | Keegan et al. | Feb 2006 | A1 |
| 20060030933 | DeLegge | Feb 2006 | A1 |
| 20060030943 | Peterman | Feb 2006 | A1 |
| 20060036241 | Siegal | Feb 2006 | A1 |
| 20060036259 | Carl et al. | Feb 2006 | A1 |
| 20060036261 | McDonnell | Feb 2006 | A1 |
| 20060036273 | Siegal | Feb 2006 | A1 |
| 20060041258 | Galea | Feb 2006 | A1 |
| 20060045904 | Aronson | Mar 2006 | A1 |
| 20060058807 | Landry et al. | Mar 2006 | A1 |
| 20060058880 | Wysocki et al. | Mar 2006 | A1 |
| 20060064171 | Trieu | Mar 2006 | A1 |
| 20060064172 | Trieu | Mar 2006 | A1 |
| 20060069439 | Zucherman et al. | Mar 2006 | A1 |
| 20060069440 | Zucherman et al. | Mar 2006 | A1 |
| 20060085002 | Trieu et al. | Apr 2006 | A1 |
| 20060085009 | Truckai et al. | Apr 2006 | A1 |
| 20060089642 | Diaz et al. | Apr 2006 | A1 |
| 20060089646 | Bonutti | Apr 2006 | A1 |
| 20060089654 | Lins et al. | Apr 2006 | A1 |
| 20060089715 | Truckai et al. | Apr 2006 | A1 |
| 20060089718 | Zucherman et al. | Apr 2006 | A1 |
| 20060089719 | Trieu | Apr 2006 | A1 |
| 20060095045 | Trieu | May 2006 | A1 |
| 20060095046 | Trieu et al. | May 2006 | A1 |
| 20060095134 | Trieu et al. | May 2006 | A1 |
| 20060095138 | Truckai et al. | May 2006 | A1 |
| 20060100706 | Shadduck et al. | May 2006 | A1 |
| 20060106397 | Lins | May 2006 | A1 |
| 20060106459 | Truckai et al. | May 2006 | A1 |
| 20060122704 | Vresilovic et al. | Jun 2006 | A1 |
| 20060129244 | Ensign | Jun 2006 | A1 |
| 20060136064 | Sherman | Jun 2006 | A1 |
| 20060142858 | Colleran et al. | Jun 2006 | A1 |
| 20060142864 | Cauthen | Jun 2006 | A1 |
| 20060149136 | Seto et al. | Jul 2006 | A1 |
| 20060149237 | Markworth et al. | Jul 2006 | A1 |
| 20060149252 | Markworth et al. | Jul 2006 | A1 |
| 20060149379 | Kuslich et al. | Jul 2006 | A1 |
| 20060149380 | Lotz et al. | Jul 2006 | A1 |
| 20060155379 | Heneveld, Sr. et al. | Jul 2006 | A1 |
| 20060161162 | Lambrecht et al. | Jul 2006 | A1 |
| 20060161166 | Johnson et al. | Jul 2006 | A1 |
| 20060167553 | Cauthen, III et al. | Jul 2006 | A1 |
| 20060173545 | Cauthen, III et al. | Aug 2006 | A1 |
| 20060178746 | Bartish, Jr. et al. | Aug 2006 | A1 |
| 20060184192 | Markworth et al. | Aug 2006 | A1 |
| 20060184247 | Edidin et al. | Aug 2006 | A1 |
| 20060184248 | Edidin et al. | Aug 2006 | A1 |
| 20060189999 | Zwirkoski | Aug 2006 | A1 |
| 20060190083 | Arnin et al. | Aug 2006 | A1 |
| 20060190085 | Cauthen | Aug 2006 | A1 |
| 20060195102 | Malandain | Aug 2006 | A1 |
| 20060195191 | Sweeney, II et al. | Aug 2006 | A1 |
| 20060200139 | Michelson | Sep 2006 | A1 |
| 20060200164 | Michelson | Sep 2006 | A1 |
| 20060200239 | Rothman et al. | Sep 2006 | A1 |
| 20060200240 | Rothman et al. | Sep 2006 | A1 |
| 20060200241 | Rothman et al. | Sep 2006 | A1 |
| 20060200242 | Rothman et al. | Sep 2006 | A1 |
| 20060200243 | Rothman et al. | Sep 2006 | A1 |
| 20060206116 | Yeung | Sep 2006 | A1 |
| 20060206207 | Dryer et al. | Sep 2006 | A1 |
| 20060235423 | Cantu | Oct 2006 | A1 |
| 20060235521 | Zucherman et al. | Oct 2006 | A1 |
| 20060241663 | Rice et al. | Oct 2006 | A1 |
| 20060241770 | Rhoda et al. | Oct 2006 | A1 |
| 20060247770 | Peterman | Nov 2006 | A1 |
| 20060247771 | Peterman et al. | Nov 2006 | A1 |
| 20060247781 | Francis | Nov 2006 | A1 |
| 20060264896 | Palmer | Nov 2006 | A1 |
| 20060264939 | Zucherman et al. | Nov 2006 | A1 |
| 20060264945 | Edidin et al. | Nov 2006 | A1 |
| 20060265067 | Zucherman et al. | Nov 2006 | A1 |
| 20060265077 | Zwirkoski | Nov 2006 | A1 |
| 20060271049 | Zucherman et al. | Nov 2006 | A1 |
| 20060271061 | Beyar et al. | Nov 2006 | A1 |
| 20060276897 | Winslow | Dec 2006 | A1 |
| 20060276899 | Zipnick et al. | Dec 2006 | A1 |
| 20060282167 | Lambrecht et al. | Dec 2006 | A1 |
| 20060287726 | Segal et al. | Dec 2006 | A1 |
| 20060287727 | Segal et al. | Dec 2006 | A1 |
| 20060293662 | Boyer, II et al. | Dec 2006 | A1 |
| 20060293753 | Thramann | Dec 2006 | A1 |
| 20070006692 | Phan | Jan 2007 | A1 |
| 20070010716 | Malandain et al. | Jan 2007 | A1 |
| 20070010717 | Cragg | Jan 2007 | A1 |
| 20070010824 | Malandain et al. | Jan 2007 | A1 |
| 20070010844 | Gong et al. | Jan 2007 | A1 |
| 20070010845 | Gong et al. | Jan 2007 | A1 |
| 20070010846 | Leung et al. | Jan 2007 | A1 |
| 20070010848 | Leung et al. | Jan 2007 | A1 |
| 20070010889 | Francis | Jan 2007 | A1 |
| 20070032703 | Sankaran et al. | Feb 2007 | A1 |
| 20070032791 | Greenhalgh | Feb 2007 | A1 |
| 20070043361 | Malandain et al. | Feb 2007 | A1 |
| 20070043362 | Malandain et al. | Feb 2007 | A1 |
| 20070043363 | Malandain et al. | Feb 2007 | A1 |
| 20070043440 | William et al. | Feb 2007 | A1 |
| 20070048382 | Meyer et al. | Mar 2007 | A1 |
| 20070049849 | Schwardt et al. | Mar 2007 | A1 |
| 20070049934 | Edidin et al. | Mar 2007 | A1 |
| 20070049935 | Edidin et al. | Mar 2007 | A1 |
| 20070050034 | Schwardt et al. | Mar 2007 | A1 |
| 20070050035 | Schwardt et al. | Mar 2007 | A1 |
| 20070055201 | Seto et al. | Mar 2007 | A1 |
| 20070055237 | Edidin et al. | Mar 2007 | A1 |
| 20070055246 | Zucherman et al. | Mar 2007 | A1 |
| 20070055265 | Schaller | Mar 2007 | A1 |
| 20070055266 | Osorio et al. | Mar 2007 | A1 |
| 20070055267 | Osorio et al. | Mar 2007 | A1 |
| 20070055271 | Schaller | Mar 2007 | A1 |
| 20070055272 | Schaller | Mar 2007 | A1 |
| 20070055273 | Schaller | Mar 2007 | A1 |
| 20070055274 | Appenzeller et al. | Mar 2007 | A1 |
| 20070055275 | Schaller | Mar 2007 | A1 |
| 20070055276 | Edidin | Mar 2007 | A1 |
| 20070055277 | Osorio et al. | Mar 2007 | A1 |
| 20070055278 | Osorio et al. | Mar 2007 | A1 |
| 20070055281 | Osorio et al. | Mar 2007 | A1 |
| 20070055284 | Osorio et al. | Mar 2007 | A1 |
| 20070055300 | Osorio et al. | Mar 2007 | A1 |
| 20070060933 | Sankaran et al. | Mar 2007 | A1 |
| 20070060935 | Schwardt et al. | Mar 2007 | A1 |
| 20070067034 | Chirico et al. | Mar 2007 | A1 |
| 20070068329 | Phan et al. | Mar 2007 | A1 |
| 20070073292 | Kohm et al. | Mar 2007 | A1 |
| 20070078436 | Leung et al. | Apr 2007 | A1 |
| 20070078463 | Malandain | Apr 2007 | A1 |
| 20070093689 | Steinberg | Apr 2007 | A1 |
| 20070093899 | Dutoit et al. | Apr 2007 | A1 |
| 20070093906 | Hudgins et al. | Apr 2007 | A1 |
| 20070123986 | Schaller | May 2007 | A1 |
| 20070135922 | Trieu | Jun 2007 | A1 |
| 20070149978 | Shezifi et al. | Jun 2007 | A1 |
| 20070150059 | Ruberte et al. | Jun 2007 | A1 |
| 20070150060 | Trieu | Jun 2007 | A1 |
| 20070150061 | Trieu | Jun 2007 | A1 |
| 20070150063 | Ruberte et al. | Jun 2007 | A1 |
| 20070150064 | Ruberte et al. | Jun 2007 | A1 |
| 20070162127 | Peterman et al. | Jul 2007 | A1 |
| 20070167945 | Lange et al. | Jul 2007 | A1 |
| 20070168038 | Trieu | Jul 2007 | A1 |
| 20070173939 | Kim | Jul 2007 | A1 |
| 20070179612 | Johnson et al. | Aug 2007 | A1 |
| 20070179615 | Heinz et al. | Aug 2007 | A1 |
| 20070179616 | Braddock, Jr. et al. | Aug 2007 | A1 |
| 20070179618 | Trieu et al. | Aug 2007 | A1 |
| 20070185578 | O'Neil et al. | Aug 2007 | A1 |
| 20070191953 | Trieu | Aug 2007 | A1 |
| 20070197935 | Reiley et al. | Aug 2007 | A1 |
| 20070198023 | Sand et al. | Aug 2007 | A1 |
| 20070198025 | Trieu et al. | Aug 2007 | A1 |
| 20070208426 | Trieu | Sep 2007 | A1 |
| 20070213717 | Trieu et al. | Sep 2007 | A1 |
| 20070219634 | Greenhalgh et al. | Sep 2007 | A1 |
| 20070233074 | Anderson et al. | Oct 2007 | A1 |
| 20070260255 | Haddock et al. | Nov 2007 | A1 |
| 20070270957 | Heinz | Nov 2007 | A1 |
| 20070282443 | Globerman et al. | Dec 2007 | A1 |
| 20080021557 | Trieu | Jan 2008 | A1 |
| 20080027437 | Johnson et al. | Jan 2008 | A1 |
| 20080027453 | Johnson et al. | Jan 2008 | A1 |
| 20080027454 | Johnson et al. | Jan 2008 | A1 |
| 20080071356 | Greenhalgh et al. | Mar 2008 | A1 |
| 20080177306 | Lamborne et al. | Jul 2008 | A1 |
| 20080195096 | Frei | Aug 2008 | A1 |
| 20080195210 | Milijasevic et al. | Aug 2008 | A1 |
| 20080229597 | Malandain | Sep 2008 | A1 |
| 20080281346 | Greenhalgh et al. | Nov 2008 | A1 |
| 20080281364 | Chirico et al. | Nov 2008 | A1 |
| 20090018524 | Greenhalgh et al. | Jan 2009 | A1 |
| 20090048678 | Saal et al. | Feb 2009 | A1 |
| Number | Date | Country |
|---|---|---|
| 197 10 392 | Jul 1999 | DE |
| 197 10 392 | Jul 1999 | DE |
| 19710392 | Jul 1999 | DE |
| 202006005868 | Jun 2006 | DE |
| 0529275 | Mar 1993 | EP |
| 0 621 020 | Oct 1994 | EP |
| 0743045 | Nov 1996 | EP |
| 1 157 676 | Nov 2001 | EP |
| 1 157 676 | Nov 2001 | EP |
| 2712486 | May 1995 | FR |
| 2 913331 | Dec 2008 | FR |
| WO 9304634 | Mar 1993 | WO |
| WO 9834552 | Aug 1998 | WO |
| 0044288 | Mar 2000 | WO |
| WO 0067650 | Nov 2000 | WO |
| WO 0067651 | Nov 2000 | WO |
| WO 0110316 | Feb 2001 | WO |
| WO 0217824 | Mar 2002 | WO |
| WO 0230338 | Apr 2002 | WO |
| WO 0243628 | Jun 2002 | WO |
| WO 0247563 | Jun 2002 | WO |
| WO 02071921 | Sep 2002 | WO |
| WO 03007854 | Jan 2003 | WO |
| WO 03020169 | Mar 2003 | WO |
| WO 03022165 | Mar 2003 | WO |
| WO 03028587 | Apr 2003 | WO |
| WO 03059180 | Jul 2003 | WO |
| WO 03101308 | Dec 2003 | WO |
| WO 2004034924 | Apr 2004 | WO |
| WO2004034924 | Apr 2004 | WO |
| WO 2004062505 | Jul 2004 | WO |
| WO 2004082526 | Sep 2004 | WO |
| WO 2004098420 | Nov 2004 | WO |
| WO 2004108022 | Dec 2004 | WO |
| 2005027734 | Mar 2005 | WO |
| WO 2005032433 | Apr 2005 | WO |
| WO 2005051246 | Jun 2005 | WO |
| WO 2005081877 | Sep 2005 | WO |
| WO 2006047587 | May 2006 | WO |
| WO 2006047645 | May 2006 | WO |
| WO 2006060420 | Jun 2006 | WO |
| WO 2006066228 | Jun 2006 | WO |
| WO 2006072941 | Jul 2006 | WO |
| WO 2006072941 | Jul 2006 | WO |
| WO 2007022194 | Feb 2007 | WO |
| WO2007067726 | Jun 2007 | WO |
| Entry |
|---|
| U.S. Appl. No. 11/464,782 (pending) to Schaller, filed Aug. 15, 2006, entitled “Spinal Tissue Distraction Devices”. |
| U.S. Appl. No. 11/464,793 (pending) to Schaller, filed Aug. 15, 2006, entitled “Devices For Limiting The Movement Of Material Introduced Between Layers Of Spinal Tissue”. |
| U.S. Appl. No. 11/464,807 (pending) to Schaller, filed Aug. 15, 2006, entitled “Methods Of Distracting Tissue Layers Of The Human Spine”. |
| U.S. Appl. No. 11/464,812 (pending) to Schaller, filed Aug. 15, 2006, entitled “Methods Of Distracting Tissue Layers Of The Human Spine”. |
| U.S. Appl. No. 11/464,815 (pending) to Schaller, filed Aug. 15, 2006, entitled “Methods For Limiting The Movement Of Material Introduced Between Layers Of Spinal Tissue”. |
| PCT/US2006/031861 (pending) to Schaller filed on Aug. 15, 2006, entitled “Spinal Tissue Distraction Devices”. |
| Carrino, John A., et al. “Vertebral Augmentation: Vertebroplasty and Kyphoplasty”, Seminars in Roentgenology, vol. 39, No. 1 (Jan.) 2004, pp. 68-84. |
| Joshi, Ajeya P., et al. “Vertebroplasty: Current Concepts and Outlook”, 2003 (9 pages), From: http://www.spineuniverse.com/displayarticle.php/article2076.html. |
| USPTO Office Action of Aug. 19, 2009 for U.S. Appl. No. 11/464,807. |
| USPTO Office Action of Apr. 1, 2010 for U.S. Appl. No. 11/464,807. |
| PCT Invitation to Pay Additional Fees (Form PCT/ISA/206), Re: International application No. PCT/US2006/031861 dated Jan. 15, 2007. |
| Annex to PCT Invitation to Pay Additional Fees, Re: International application No. PCT/US2006/031861 dated Jan. 15, 2007. |
| PCT Notification concerning transmittal of International Preliminary report on patentability and PCT Written Opinion of the International Searching Authority, PCT Application No. US2006/031861 dated Feb. 28, 2008. |
| Notification of Transmittal of International Search Report, International Search Report and Written Opinion for PCT/US08/54590 dated Aug. 22, 2008. |
| Notification of Transmittal of International Search Report, International Search Report and Written Opinion for PCT/US08/54508 dated Aug. 27, 2008. |
| U.S. Appl. No. 60/689,570, filed Jun. 13, 2005; Inventor: Tzony Siegal: Title: Directional Drilling System. |
| U.S. Appl. No. 60/557,246, filed Mar. 29, 2004 entitled: Device and Methods to Reduce and Stabilize Broken Bones. |
| Office Action from U.S. Appl. No. 11/464,807 dated Dec. 22, 2010, 10 pages. |
| Office Action issued in European Patent App. No. 06801545.2 dated May 30, 2011. |
| Translation of Office Action issued in Japanese Patent App. No. 2008-527067 dated May 13, 2011. |
| Office Action issued in Australian Patent App. No. 2006279558 dated Aug. 8, 2011. |
| USPTO Office Action of Sep. 29, 2011 for U.S. Appl. No. 12/034,853. |
| USPTO Office Action of Apr. 6, 2012 for U.S. Appl. No. 12/034,853. |
| USPTO Office Action of Jun. 21, 2011 for U.S. Appl. No. 12/389,583. |
| USPTO Office Action of Sep. 29, 2010 for U.S. Appl. No. 12/410,961. |
| USPTO Office Action of May 11, 2011 for U.S. Appl. No. 12/410,961. |
| Office Action issued in Canadian Patent Application No. 2,617,872 dated Jul. 13, 2012. |
| Edeland, H.G., “Some Additional Suggestions For An Intervetebral Disc Prosthesis”, J of BioMedical Engr., vol. 7(1) pp. 57-62, Jan. 1985. |
| Canadian Office Action dated Jan. 2, 2013, for Application No. 2,617,872, entitled: Spinal Tissue Distraction Devices. |
| Japanese Office Action, mailing date Mar. 7, 2013, for Japanese Patent Application No. 2011-201882. |
| European search report, dated May 7, 2013, for Application No. 08730333.5-1506/2124777 PCT/US2008054508. |
| USPTO Office Action of Jul. 12, 2012 for U.S. Appl. No. 13/162,021. |
| USPTO Office Action of Dec. 20, 2013 for U.S. Appl. No. 12/410,961. |
| USPTO Office Action of Jan. 10, 2014 for U.S. Appl. No. 13/794,977. |
| USPTO Office Action of Feb. 26, 2014 for U.S. Appl. No. 13/161,956. |
| USPTO Office Action of Feb. 27, 2014 for U.S. Appl. No. 13/162,021. |
| USPTO Office Action of Apr. 21, 2014 for U.S. Appl. No. 12/389,583. |
| European Search Report, dated Feb. 10, 2014, for application No. EP 13169809.4-1654. |
| Number | Date | Country | |
|---|---|---|---|
| 20110307063 A1 | Dec 2011 | US |
| Number | Date | Country | |
|---|---|---|---|
| 60784185 | Mar 2006 | US | |
| 60738432 | Nov 2005 | US | |
| 60708691 | Aug 2005 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 12705895 | Feb 2010 | US |
| Child | 13161956 | US | |
| Parent | 11464790 | Aug 2006 | US |
| Child | 12705895 | US |
